4Front Ventures (FFNTF) 10-Q 15 Aug 22 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Aug. 15, 2022
Document Information [Line Items]
Entity Registrant Name	4Front Ventures Corp.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001783875
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56075
Entity Incorporation, State or Country Code	A1
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		636,636,686
Entity Address, Address Line One	5060 N. 40th Street
Entity Address, Address Line Two	Suite 120
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85018
City Area Code	602
Local Phone Number	633-3067
Entity Tax Identification Number	83-4168417
Class A Subordinate Voting Share [Member]
Document Information [Line Items]
Trading Symbol	FFNTF
Security Exchange Name	NONE
Title of 12(b) Security	Class A Subordinate Voting Shares, no par value
ADR [Member]
Document Information [Line Items]
Trading Symbol	FFNT
Security Exchange Name	NONE
Title of 12(b) Security	Class A Subordinate Voting Shares, no par value

CONDENSED CONSOLIDATED INTERIM

CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 6,032	$ 22,581
Accounts receivable, net	5,844	1,946
Other receivables	33	289
Current portion of lease receivables	3,405	3,630
Inventory	28,837	20,087
Current portion of notes receivable	0	109
Prepaid expenses	2,974	2,232
Total current assets	47,125	50,874
Property, plant, and equipment, net	58,967	42,633
Lease receivables	6,541	6,748
Intangible assets, net	54,239	26,246
Goodwill	42,037	23,155
Right-of-use assets	106,406	100,519
Deposits	5,142	5,364
TOTAL ASSETS	320,457	255,539
Current liabilities:
Accounts payable	6,391	2,131
Accrued expenses and other current liabilities	13,031	9,411
Taxes payable	29,651	23,968
Derivative liability	428	3,502
Current portion of contract liabilities	1,535	0
Current portion of convertible notes	0	2,784
Current portion of lease liability	4,121	3,629
Current portion of notes payable and accrued interest	8,235	3,413
Total current liabilities	63,392	48,838
Convertible notes	15,205	14,641
Notes payable and accrued interest from related party	49,366	48,266
Long term notes payable	10,128	1,709
Long term accounts payable	1,200	1,200
Contract liabilities	2,000	0
Contingent consideration payable	0	2,393
Construction finance liability	16,000	0
Deferred tax liability	6,884	7,849
Lease liability	101,380	93,111
TOTAL LIABILITIES	265,555	218,007
SHAREHOLDERS' EQUITY
Equity attributable to 4Front Ventures Corp.	302,502	274,120
Additional paid-in capital	53,625	52,197
Deficit	(301,307)	(288,857)
Non-controlling interest	82	72
TOTAL SHAREHOLDERS' EQUITY	54,902	37,532
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 320,457	$ 255,539

CONDENSED CONSOLIDATED INTERI_2

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
REVENUE
Revenue from sale of goods	$ 25,488	$ 24,452	$ 48,571	$ 44,532
Real estate income	2,951	2,669	5,916	5,559
Total revenues	28,439	27,121	54,487	50,091
Cost of goods sold	(16,123)	(10,816)	(28,717)	(19,941)
Gross profit	12,316	16,305	25,770	30,150
OPERATING EXPENSES
Selling and marketing expenses	6,327	6,714	11,493	11,871
General and administrative expenses	6,566	5,083	14,210	10,248
Depreciation and amortization	1,123	861	1,970	1,635
Transaction and restructuring related expenses	2,009	0	2,009	0
Equity based compensation	390	2,979	1,428	5,375
Total operating expenses	16,415	15,637	31,110	29,129
(Loss) Income from operations	(4,099)	668	(5,340)	1,021
Other income (expense)
Interest income	0	8	2	11
Interest expense	(3,418)	(2,901)	(6,038)	(5,362)
Amortization of loan discount upon conversion of debt to equity	0	0	0	(2,915)
Change in fair value of derivative liability	1,774	(311)	3,074	(2,843)
Change in contingent consideration payable	2,393	0	2,393	0
Loss on lease termination	0	(331)	0	(1,210)
Other	(154)	0	(51)	0
Total other income (expense), net	595	(3,535)	(620)	(12,319)
Net loss before income taxes	(3,504)	(2,867)	(5,960)	(11,298)
Income tax expense	(3,042)	(3,351)	(6,480)	(6,004)
Net loss	(6,546)	(6,218)	(12,440)	(17,302)
Net income attributable to non-controlling interest	5	5	10	10
Net loss attributable to shareholders	$ (6,551)	$ (6,223)	$ (12,450)	$ (17,312)
Basic loss per share	$ 0.01	$ 0.01	$ 0.02	$ 0.03
Diluted loss per share	$ 0.01	$ 0.01	$ 0.02	$ 0.03
Weighted average number of shares outstanding, basic	636,653,975	587,218,794	628,175,765	573,108,183
Weighted average number of shares outstanding, diluted	636,653,975	587,218,794	628,175,765	573,108,183

CONDENSED CONSOLIDATED INTERI_3

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Om of Medicine	Share Capital	Share Capital Om of Medicine	Additional Paid-In Capital	Deficit	Total 4Front Ventures Corp. Shareholders' Equity	Total 4Front Ventures Corp. Shareholders' Equity Om of Medicine	Non-Controlling Interest
Beginning Balance at Dec. 31, 2020	$ 42,203		$ 250,583		$ 42,116	$ (250,548)	$ 42,151		$ 52
Beginning Balance, Shares at Dec. 31, 2020	538,851,252		538,851,252
Shares issued for Pure Ratios earnout	$ 161		$ 161				161
Shares issued for Pure Ratios earnout, shares			473,491
Share-based compensation	2,396				2,396		2,396
Conversion of notes to equity	6,253		$ 6,253				6,253
Conversion of notes to equity, shares			24,366,003
Shares issued with exercise of stock options	871		$ 871				871
Shares issued with exercise of stock options, shares			1,358,116
Shares issued with exercise of warrants	1,563		$ 1,563				1,563
Shares issued with exercise of warrants, shares			2,422,363
Return of treasury shares			(8,320)
Net loss	(11,084)		$ 0		0	(11,089)	(11,089)		5
Ending Balance at Mar. 31, 2021	42,363		$ 259,431		44,512	(261,637)	42,306		57
Ending Balance, Shares at Mar. 31, 2021			567,462,905
Beginning Balance at Dec. 31, 2020	$ 42,203		$ 250,583		42,116	(250,548)	42,151		52
Beginning Balance, Shares at Dec. 31, 2020	538,851,252		538,851,252
Net loss	$ (17,302)
Ending Balance at Jun. 30, 2021	53,568		$ 273,875		47,491	(267,860)	53,506		62
Ending Balance, Shares at Jun. 30, 2021			593,898,521
Beginning Balance at Mar. 31, 2021	42,363		$ 259,431		44,512	(261,637)	42,306		57
Beginning Balance, Shares at Mar. 31, 2021			567,462,905
Shares issued for Pure Ratios earnout		$ 722		$ 722				$ 722
Shares issued for Pure Ratios earnout, shares				535,018
Share-based compensation	2,979				2,979		2,979
Conversion of notes to equity	11,466		$ 11,466				11,466
Conversion of notes to equity, shares			24,676,794
Shares issued with exercise of stock options	443		$ 443				443
Shares issued with exercise of stock options, shares			652,940
Shares issued with exercise of warrants	1,813		$ 1,813				1,813
Shares issued with exercise of warrants, shares			570,864
Net loss	(6,218)					(6,223)	(6,223)		5
Ending Balance at Jun. 30, 2021	53,568		$ 273,875		47,491	(267,860)	53,506		62
Ending Balance, Shares at Jun. 30, 2021			593,898,521
Beginning Balance at Dec. 31, 2021	$ 37,532		$ 274,120		52,197	(288,857)	37,460		72
Beginning Balance, Shares at Dec. 31, 2021	594,181,604		594,181,604
Share-based compensation	$ 1,038				1,038		1,038
Conversion of notes to equity	3,122		$ 3,122				3,122
Conversion of notes to equity, shares			6,235,512
Shares issued with exercise of warrants	50		$ 50				50
Shares issued with exercise of warrants, shares			88,659
Shares issued for Island pursuant to acquisition	18,200		$ 18,200				18,200
Shares issued for Island pursuant to acquisition, shares			28,571,428
Net loss	(5,894)					(5,899)	(5,899)		5
Ending Balance at Mar. 31, 2022	54,048		$ 295,492		53,235	(294,756)	53,971		77
Ending Balance, Shares at Mar. 31, 2022			629,077,203
Beginning Balance at Dec. 31, 2021	$ 37,532		$ 274,120		52,197	(288,857)	37,460		72
Beginning Balance, Shares at Dec. 31, 2021	594,181,604		594,181,604
Net loss	$ (12,440)
Ending Balance at Jun. 30, 2022	$ 54,902		$ 302,502		53,625	(301,307)	54,820		82
Ending Balance, Shares at Jun. 30, 2022	637,912,894		637,912,894
Beginning Balance at Mar. 31, 2022	$ 54,048		$ 295,492		53,235	(294,756)	53,971		77
Beginning Balance, Shares at Mar. 31, 2022			629,077,203
Share-based compensation	390				390		390
Shares issued with exercise of stock options	33		$ 33				33
Shares issued with exercise of stock options, shares			51,975
Shares issued for Island pursuant to acquisition	6,245		$ 6,245				6,245
Shares issued for Island pursuant to acquisition, shares			8,783,716
Warrants issued for Island pursuant to acquisition	732		$ 732				732
Net loss	(6,546)					(6,551)	(6,551)		5
Ending Balance at Jun. 30, 2022	$ 54,902		$ 302,502		$ 53,625	$ (301,307)	$ 54,820		$ 82
Ending Balance, Shares at Jun. 30, 2022	637,912,894		637,912,894

CONDENSED CONSOLIDATED INTERI_4

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (12,440)	$ (17,302)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	4,689	2,166
Equity based compensation	1,428	5,375
Change in fair value of derivative liability	(3,074)	2,843
Change in fair value of contingent consideration	(2,393)	0
Amortization of right-of-use assets	0	1,765
Accretion of lease liability	2,803	(478)
Write-off of fixed asset from terminated lease	0	1,210
Accretion of contingent consideration	0	228
Accretion of convertible debenture and interest	564	850
Accrued interest on notes payable	3,614	3,884
Interest accrued - lease receivable	432	349
Deferred taxes	(965)	632
Amortization of loan discount upon conversion of debt to equity	0	2,915
Changes in operating assets and liabilities	2,458	(170)
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	(2,884)	4,267
CASH FLOWS FROM INVESTING ACTIVITIES
Payment for NECC business combination, net of cash acquired	(24,998)	0
Cash acquired as part of Island business combination	458	0
Notes receivable repayments	109	405
Sale of dispensaries and interests in cannabis licenses	0	1,093
Purchases of property and equipment	(2,249)	(12,234)
NET CASH USED IN INVESTING ACTIVITIES	(26,680)	(10,736)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of contingent consideration	(412)	(1,204)
Proceeds from issuance of construction financing liability	16,000	0
Proceeds from the exercise of warrants	50	1,664
Proceeds from the exercise of stock options	33	1,314
Repayment of notes payable	(2,656)	(2,674)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	13,015	(900)
NET DECREASE IN CASH	(16,549)	(7,369)
CASH, BEGINNING OF QUARTER	22,581	18,932
CASH, END OF QUARTER	$ 6,032	$ 11,563

Nature of Operations

Nature of Operations	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Note 1: NATURE OF OPERATIONS 4Front Ventures Corp. (“4Front” or the “Company”) exists pursuant to the provisions of the British Columbia Corporations Act. On July 31, 2019, 4Front Holdings LLC (“Holdings”) completed a Reverse Takeover Transaction (“RTO”) with Cannex Capital Holdings Inc. (“Cannex”) whereby Holdings acquired Cannex and the shareholders of Holdings became the controlling shareholders of the Company. Following the RTO, the Company’s SVS are listed on the Canadian Securities Exchange (“CSE”) under the ticker “FFNT” and are quoted on the OTC (OTCQX: FFNTF). The Company has two primary operating segments: THC Cannabis and CBD Wellness. With regard to its THC Cannabis segment, as of June 30, 2022, the Company operates six dispensaries in Massachusetts, Illinois, and Michigan, primarily under the “MISSION” brand name. As of June 30, 2022, the Company operates three production facilities in Massachusetts, Illinois and California and produces the majority of products that are sold at its own Massachusetts and Illinois dispensaries. Also, as part of its THC Cannabis segment, the Company leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington. While marijuana is legal under the laws of several U.S. states (with varying restrictions), the United States Federal Controlled Substances Act classifies all “marijuana” as a Schedule 1 drug, whether for medical or recreational use. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. The Company’s CBD Wellness segment is focused upon its ownership and operation of its wholly owned subsidiary, Pure Ratios Holdings, Inc. (“Pure Ratios”), a CBD-focused non-THC On January 28, 2022, the Company entered into an agreement and plan of merger (the “NECC Merger Agreement”) with New England Cannabis Corporation, Inc., a Massachusetts Corporation (“NECC”) and a wholly owned subsidiary of the Company entered into an amended membership interest purchase agreement (the “Everett Purchase Agreement,” and together with the NECC Merger Agreement, the “NECC Merger Agreements”) with Kenneth Stevens to purchase all of the membership interests of 29 Everett, LLC (“29 Everett”), a Massachusetts limited liability company. See Note 7 for further details on the NECC Merger Agreements and corresponding transactions under such agreements. On March 30, 2022, the Company entered into an agreement and plan of merger (the “Island Merger Agreement”) by and among the Company, Island Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Island Merger Sub”); Island Global Holdings, Inc., a California corporation (“Island”); and Navy Capital SR LLC, a Delaware limited liability company (“Navy”, and together with the Company, Island Merger Sub, and Island, the “Island Parties”). In April 2022, pursuant to the terms and conditions of the Merger Agreement, Island Merger Sub merged with and into Island, with Island surviving the merger and continuing its corporate existence as a wholly owned subsidiary of the Company (the “Island Merger”). See Note 7 for further details on the Island Merger Agreements and corresponding transactions under such agreements. Management continues to evaluate the impact of the COVID-19 The corporate office address of the Company is 5060 North 40th Street, Suite 120, Phoenix, Arizona, and the Company’s registered office is 550 Burrard Street, Suite 2900, Vancouver, British Columbia.

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Note 2: BASIS OF PRESENTATION The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s Annual Report on Form 10-K, 10-K, There have been no changes to the Company’s significant accounting policies as described in Note 2 of the Company’s 2021 Annual Report on Form 10-K. Principles of consolidation The accompanying condensed consolidated interim financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. The financial results of NECC are included in the condensed consolidated financial statements beginning on January 28, 2022, the merger closing date. The financial results of Island are included in the condensed consolidated financial statements beginning on April 25, 2022, the merger closing date. The financial statements of the subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Note 3: SIGNIFICANT ACCOUNTING POLICIES (a) Critical accounting estimates and judgments Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the Company’s condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods. The significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those described in the latest annual consolidated financial statements, except for additional accounting policies identified during the interim period noted below. Contract Assets and Liabilities To the extent that the customer has paid consideration before transferring goods or services to the customer, a contract liability is recorded on the consolidated balance sheet as current portion of contract liabilities for contract liabilities due within twelve months or contract liabilities for contract liabilities due after twelve months. When the Company has an unconditional right to payment, a receivable is recorded on the consolidated balance sheet as current portion of contract assets for contract assets due within twelve months or contract assets for contract assets due after twelve months. Amounts expected to be recognized as revenue within the twelve months following the balance sheet date are classified as current portion of contract liabilities in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the twelve months following the balance sheet date are classified as contract liabilities. The accompanying condensed balance sheets reflect a contract liability for the amount of revenue to be recognized in the future as and when the Company satisfies its remaining performance obligations. As of June 30, 2022, in connection with the Island Merger, the Company had recogn ized $ of contract liabilities, $ of which were recorded as current liabilities and $ were recorded as long term liabilities. See Note 7 for further discussion on the Island Merger. We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary. (b) Recent Accounting Pronouncements Recently Adopted i. In August 2020, the FASB issued ASU 2020-06, 470-20) 815-40)”. 2020-06 2020-06 ii. In May 2021, the FASB issued ASU 2021-04, 815-40)”. 2021-04 2021-04 iii. In October 2021, the FASB issued ASU 2021-08, “Business Combinations—Accounting for Contract Assets and Contract Liabilities (Topic 805)”. The amendments in this update address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination by requiring that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. As a result of the amendments made by the ASU, it is expected than an acquirer will generally recognize and measure acquired contract assets and contract liabilities in a manner consistent with how the acquiree recognized and measured them in its pre-acquisition financial statements. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. An entity that early adopts in an interim period should apply the amendments (i) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (ii) prospectively to all business combinations that occur on or after the date of initial application. The Company has elected to early adopt this standard as of January 1, 2022. The adoption of the standard had an impact on the valuation of Island deferred revenue contracts upon the acquisition date. The Company recognized the contract liabilities acquired consistent with the previous accounting treatment at the acquired entity. This standard did not have an impact on the NECC acquisition entered into on January 28, 2022. Accounting Pronouncements Not Yet Adopted i. In June 2022, the FASB issued ASU 2022-03, 2022-03 2022-03

Inventory

Inventory	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventory	Note 4: INVENTORY The Company’s inventories include the following as of June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Raw materials - unharvested cannabis $ 2,849 $ 2,164 Raw materials - harvested and purchased cannabis 10,824 3,045 Packaging and other non-finished 2,986 1,734 Work in process - manufactured and purchased extracts 4,825 4,771 Finished goods 7,353 8,373 Total $ 28,837 $ 20,087

Property Plant and Equipment

Property Plant and Equipment	6 Months Ended
	Jun. 30, 2022
Property Plant and Equipment Income Statement Disclosures [Abstract]
Property, Plant and Equipment	Note 5: PROPERTY, PLANT, AND EQUIPMENT Property, plant and equipment and related depreciation are summarized in the table below: June 30, December 31, Land $ 775 $ — Buildings & improvements 13,896 1,483 Construction in process 702 63 Furniture, equipment & other 17,974 13,425 Leasehold improvements 36,878 35,538 Total $ 70,225 $ 50,509 Less: accumulated depreciation (11,258 ) (7,876 ) Total property, plant, and equipment, net $ 58,967 $ 42,633 On January 28, 2022, in conjunction with a business combination with NECC, the Company acquired property, plant, and equipment totaling $15,238 (Note 7). The Company subsequently sold the property, plant, and equipment to a third-party and leased back the equipment from the third-party. As discussed in Note 9, the Company recognized this fact pattern as a failed sale-leaseback transaction, whereby the Company recognized the fixed assets on the balance sheet of NECC and established a construction finance liability for rental payments made as part of the lease agreement. On April 25, 2022, in conjunction with a business combination with Island, the Company acquired property and equipment totaling $2,214. (Note 7). Approximately $33,000 of property and equipment is secured by LI Lending as collateral on the LI Lending note (Note 9). There were no significant contractual commitments for future capital expenditures as of June 30, 2022 and December 31, 2021. Depreciation of property, plant, and equipment is computed using the

Intangible Assets and Goodwill

Intangible Assets and Goodwill	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Note 6: INTANGIBLE ASSETS AND GOODWILL Intangible Assets Intangible assets are recorded at cost less accumulated amortization and impairment losses. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is recognized on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Intangible assets and related amortization are summarized in the table below: Licenses Customer Non-Competition Know-How Tradenames Total Balance, December 31, 2020 $ 20,146 $ 1,668 $ 43 $ 6,933 $ — $ 28,790 Amortization expense — (580 ) (43 ) (1,921 ) — (2,544 ) Balance, December 31, 2021 $ 20,146 $ 1,088 $ — $ 5,012 $ — $ 26,246 NECC merger and 29 Everett acquisition (Note 7) 18,000 — — — — 18,000 Island merger (Note 7) 8,700 — — — 2,600 11,300 Amortization expense — (290 ) (970 ) (47 ) (1,307 ) Balance, June 30, 2022 $ 46,846 $ 798 $ — $ 4,042 $ 2,553 $ 54,239 Goodwill Balance, December 31, 2020 $ 23,155 Balance, December 31, 2021 $ 23,155 NECC merger and 29 Everett acquisition (Note 7) 12,547 Island merger (Note 7) 6,335 Balance, June 30, 2022 $ 42,037 Impairment of Intangible Assets and Goodwill On an annual basis, the Company assesses the Company’s reporting units (“RUs”) for indicators of impairment or when facts or circumstances suggest that it is more likely than not that the carrying amount may exceed fair value. For the purpose of impairment testing, goodwill is allocated to the Company’s RUs to which it relates. Goodwill was not tested for impairment during the six months ended June 30, 2022. Six Months Ended June 30, 2022 On January 28, 2022, the Company entered into the NECC Merger Agreements with NECC and 29 Everett for total consideration of $45,200. As part of the purchase price allocation of the acquisition and merger, the Company recognized $18,000 of acquired licenses and $12,547 of goodwill based on the consideration transferred and fair value of net On April 25, 2022, the Company entered into the Island Merger Agreement with Island for total consideration of $16,977. As part of the purchase price allocation of the acquisition and merger, the Company recognized $8,700 of acquired licenses, $2,600 of trade names and trademarks and $6,335 of goodwill based on the consideration transferred and fair value of net For further details on the acquisitions and purchase price allocations, see Note 7. Year Ended December 31, 2021 In 2021, management assessed indicators of impairment and concluded the below for the respective RUs: Retail, Production and Ancillary Cannabis Reporting Units Management did not identify any significant negative triggering events that would suggest it is more likely than not that impairment exists. Therefore, further analysis was not required for these RUs. Pure Ratios RU As of June 30, 2022 and December 31, 2021, the accumulated impairment is $13,400, which is due to goodwill impairment of the entire outstanding balance of goodwill on the Pure Ratios segment for the year ended December 31, 2020. As a result, the segment does not have a balance of goodwill or intangible assets remaining as of December 31, 2021.

Acquisitions And Business Combi

Acquisitions And Business Combinations	6 Months Ended
	Jun. 30, 2022
Business Combinations [Abstract]
Acquisitions and Business Combinations	Note 7: ACQUISITIONS AND BUSINESS COMBINATIONS NECC Merger Agreement On January 28, 2022, the Company entered into the merger agreement (the “NECC Merger”) with NECC, Kenneth V. Stevens (“Mr. Stevens”), who is the sole owner of all of the issued and outstanding capital stock of NECC, and 4Front NECC Acquisition Co., a Massachusetts corporation (the “NECC Merger Sub”). At the effective time of the merger, the Company (i) paid Mr. Stevens cash in the amount of $9,000,000, and (ii) issued Mr. Stevens 28,571,428 Class A Subordinate Voting shares of the Company (the “SVS”). In connection with the consummation of the NECC Merger on January 28, 2022, Mission Partners RE, LLC, a Delaware limited liability company wholly owned by the Company (“Mission Partners RE”), and Mr. Stevens entered into the first amendment to that certain membership interest purchase agreement (the “Everett Purchase Agreement”). Pursuant to the Everett Purchase Agreement, the Company (through Mission Partners RE) completed its acquisition of 100% of the issued and outstanding membership interests of 29 Everett Street LLC, a Massachusetts limited liability company (the “Everett LLC”), which was solely held by Mr. Stevens and which owns certain real property that is currently leased to and used by NECC. The Company (i) paid Mr. Stevens cash in the amount of $16,000,000, and (ii) issued Mr. Stevens a promissory note in the initial principal amount of $2,000,000, which will bear interest at an annual rate of ten percent (10%) and mature d six-month On July 28, 2022, the parties amended the promissory note to provide for payment of half the principal on the initial maturity date, and the remaining principal and all accrued interest on September 12, 2022. The Merger and Purchase Agreement were recorded as one transaction (collectively, referred to as the “NECC Acquisitions”), as the entities were commonly owned by the same individual and the purchase of Everett LLC was contingent on the Merger with NECC. The NECC Merger was accounted for as a business combination in accordance with ASC 805. The Company has determined preliminary fair values of the assets acquired and liabilities assumed in the NECC Merger. These values are subject to change as the Company completes its determination of the fair value of assets acquired and liabilities assumed. Upon acquisition of NECC and Everett LLC on January 28, 2022, the Company consolidated the operations of Everett LLC into NECC. As of the date of acquisition, the Company recognized NECC under the THC Cannabis segment as part of segment reporting. The Company entered into the NECC Merger in order to acquire cannabis licenses, as well as property and equipment held by NECC to increase the Company’s presence in Massachusetts and the northeastern United States. As part of the NECC, the Company incurred $130 in restructuring costs, which were included in transaction and restructuring related expenses and expensed as incurred. As part of the NECC Merger, the Company incurred $544 in transaction costs, which were included in transaction and restructuring related expenses and expensed as incurred. The following tables present the preliminary purchase price allocation for the NECC Merger: Cash consideration $ 25,000 Seller note 2,000 Equity consideration - common stock 18,200 Total Purchase Price $ 45,200 Description Fair value Assets acquired: Cash $ 2 Inventory 213 Property, plant, and equipment 15,238 Intangible asset - licenses 18,000 Total assets acquired $ 33,453 Liabilities assumed: Accounts payable 800 Total liabilities assumed $ 800 Estimated fair value of net assets acquired $ 32,653 Estimated Goodwill $ 12,547 Goodwill and Intangible Assets Goodwill is represented by the future potential for the generation of positive cash flows and future relationships associated with the Company’s operations. While NECC had yet to generate revenues as of the date of the Merger, the Company identified that the inputs of the business were in place to begin generating revenue during fiscal year 2022. The Company adjusts provisional goodwill balance when new information is obtained regarding the valuation of acquired assets and liabilities during a one-year 805-10. The intangible assets acquired by the Company consist of cannabis licenses for operations. Utilizing alike licenses as a benchmark, the Company determined that the licenses acquired are indefinite lived assets. Island Merger Agreement On March 30, 2022, the Company entered into an agreement and plan of merger (the “Island Merger Agreement”) by and among the Company, Island Merger Sub, Island, and Navy (together the “Island Parties”). Pursuant to the terms and conditions of the Merger Agreement, Island Merger Sub merged with and into Island, with Island surviving the merger and continuing its corporate existence as a wholly owned subsidiary of the Company (the “Island Merger”). The Island Merger Agreement was to be effective as of April 25, 2022 (the “Effective Date”). On the Effective Date, the Island Parties consummated the Island Merger, pursuant to the terms and conditions of the Island Merger Agreement, as amended. However, due to administrative and technical issues at the California Office of the Secretary of State, the Island Parties did not receive the certificate of merger evidencing the closing of the Island Merger as of the Effective Date until April 25, 2022. At the Effective Date, pursuant to the terms and conditions of the Island Merger Agreement, as amended, the Company issued to certain shareholders and debtholders of Island an aggregate of: (i) 8,783,716 Class A Subordinated Voting Shares of the Company (the “SVS”); (ii) 6% 54-month, On April 22, 2022, the Parties entered into the first amendment to the Island Merger Agreement to replace the requirement that certain noteholders fund a letter of credit to Island of up to $1,000,000. In lieu of funding a letter The Island Merger was accounted for as a business combination in accordance with ASC 805. The Company has determined preliminary fair values of the assets acquired and liabilities assumed in the Island Merger. These values are subject to change as the Company completes its determination of the fair value of assets acquired and liabilities assumed. Upon acquisition of Island and Navy on April 25, 2022, the Company consolidated the operations of Navy into Island. As of the date of acquisition, the Company recognized Island under the THC Cannabis segment as part of segment reporting. The Company entered into the Island Merger in order to add new high-quality products to the Company’s growing brand portfolio, including diverse lines of pre-rolls, $ The following tables present the preliminary purchase price allocation for the Island Merger: Seller note $ 10,000 Equity consideration - common stock 6,245 Equity consideration - warrants 732 Total Purchase Price $ 16,977 Description Fair value Assets acquired: Cash $ 458 Accounts receivable 876 Inventory 3,072 Prepaid expenses and other current assets 424 Property and equipment, net 2,214 Operating lease - right of use asset 10,227 Intangible assets 11,300 Total assets acquired $ 28,571 Liabilities assumed: Accounts payable $ 1,356 Accrued expenses and other liabilities 2,566 Contract liabilities 3,535 Lease liabilities 10,227 Notes payable 245 Total liabilities assumed $ 17,929 Estimated fair value of net assets acquired $ 10,642 Estimated Goodwill $ 6,335 Goodwill and Intangible Assets Goodwill is represented by the future potential for the generation of positive cash flows and future relationships associated with the Company’s operations. The Company adjusts provisional goodwill balance when new information is obtained regarding the valuation of acquired assets and liabilities during a one-year 805-10. The intangible assets acquired by the Company consist of cannabis licenses , Unaudited Pro Forma Results The following unaudited pro forma financial information presents the results of operations of the Company, NECC, and Island for the six months ended June 30, 2022 and 2021, as if the acquisitions had occurred as of the beginning of the first period presented instead of on January 28 and April 25, 2022, respectively. The pro forma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during those periods. The unaudited pro forma financial information for the Company including NECC and Island for the three months ended June 30, 2022 is as follows: For the For the Three Months Ended June 30, 2022 2021 Reported Proforma Reported Proforma Revenues $ 28,439 $ 28,706 $ 27,121 $ 28,922 (Loss) income from operations (4,099 ) (5,444 ) 668 (936 ) Net loss $ (6,546 ) $ (8,932 ) $ (6,218 ) $ (8,115 ) Basic and diluted earning (loss) per share $ (0.01 ) $ (0.01 ) $ (0.01 ) $ (0.01 ) The unaudited pro forma financial information for the Company including NECC and Island for the six months ended June 30, 2022 is as follows: For the For the Six Months Ended June 30, 2022 2021 Reported Proforma Reported Proforma Revenues $ 54,487 $ 56,113 $ 50,091 $ 53,286 (Loss) income from operations (5,340 ) (9,399 ) 1,021 (2,490 ) Net loss $ (12,440 ) $ (20,817 ) $ (17,302 ) $ (20,813 ) Basic and diluted earning (loss) per share $ (0.02 ) $ (0.03 ) $ (0.02 ) $ (0.04 )

Leases

Leases	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Leases	Note 8: LEASES The Company has operating leases for its facilities where the Company conducts its operations. These leases have remaining lease terms ranging from 1 year to 19.2 years. All real estate leases are recorded on the balance sheet. Equipment and other non-real right-of-use non-lease non-lease The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. There are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space. The Company’s lease agreements occasionally provide an implicit borrowing rate. When implicit borrowing rates are provided, the Company utilizes these implicit borrowing rates to calculate right-of-use For the three months ended June 30, 2022 and 2021 the Company recorded $2,595 and $2,400 in operating lease expense, respectively. For the six months ended six months ended June 30, 2022 and 2021 the Company recorded $7,417 and $4,868 in operating lease expense, respectively. (a) The Company as a Lessee The following table summarizes the Company’s operating leases: Classification - Consolidated Balance Sheet June 30, 2022 December 31, 2021 Assets Operating lease assets Operating Lease Assets $ 106,406 $ 100,519 Liabilities Current Operating Current portion of operating lease liabilities 4,121 3,629 Noncurrent Operating Operating lease liabilities 101,380 93,111 Total lease liabilities $ 105,501 $ 96,740 The components of lease expense are included in cost of goods sold, general and administrative expenses, and selling and marketing expenses, based on the underlying use of the right-of-use Maturities of lease liabilities for third-party operating leases as of June 30, 2022 were as follows: Operating Leases 2022 $ 8,329 2023 16,987 2024 17,491 2025 17,633 2026 18,056 2027 18,076 2028 and Thereafter 234,359 Total undiscounted cash flows $ 330,931 Less discounting (225,430 ) Total lease payments $ 105,501 The Company has right-of-use (b) The Company as a Lessor: The Company leases a building in Elma, Washington that is subleased by the Company to a third party. This sublease is classified as a finance lease with a long term lease receivable balance of $6,541 and a short term lease receivable balance of $3,405 as of June 30, 2022 compared to a long term lease receivable balance of $6,748 and a short term lease receivable balance of $3,630 as of December 31, 2021. This lease generated $676 of the $2,951 and $570 of the $2,669 in real estate income for the three months ended June 30, 2022 and 2021, respectively. This lease generated $1,368 of the $5,916 and $1,361 of the $5,559 in real estate income for the six months ended June 30, 2022 and 2021, respectively. The Company owned buildings in Olympia, Washington that were leased to a third party. This lease was classified as a finance lease. On December 17, 2020, the Company sold the Olympia building and other assets as part of a sale and leaseback transaction and this lease was cancelled. The Company applied ASC 842 to a new sublease to the same third party and classified the new sublease as an operating lease. The lease receivable was sold to the purchaser of the assets as part of the sale and leaseback transaction. This lease generated $2,275 of the $2,951 and $2,099 of the $2,669 in real estate income for the three months ended June 30, 2022 and 2021, respectively. This lease generated $4,548 of the $5,916 and $4,198 of the $5,559 in real estate income for the six months ended June 30, 2022 and 2021, respectively. The following table summarizes changes in the Company’s lease receivables: June 30, 2022 December 31, 2021 Balance, beginning of the year $ 10,378 $ 11,045 Interest 1,368 2,783 Lease payments received (1,800 ) (3,450 ) Balance, end of the period $ 9,946 $ 10,378 Less current portion (3,405 ) (3,630 ) Long-term lease receivables $ 6,541 $ 6,748 Future minimum lease payments receivable (principal and interest) on the leases are as follows: Operating Leases 2022 $ 1,830 2023 1,575 2024 — 2025 — 2026 — Thereafter — Total minimum lease payments 3,405 Effect of discounting (431 ) Present value of minimum lease payments 2,974 Present value of residual value of leased property 6,972 Total lease receivable 9,946 Current portion lease receivable (3,405 ) Long-term lease receivable $ 6,541

Notes Payable and Convertible N

Notes Payable and Convertible Notes	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Notes Payable and Convertible Notes	Note 9: NOTES PAYABLE AND CONVERTIBLE NOTES The Company’s notes payable and convertible notes are as follows: LI Lending, May 2020 2022 Island May 2020 October 2021 Other Total Balance, December 31, 2020 $ 45,362 $ 2,855 $ — $ 11,867 $ — $ 6,931 $ 67,015 Loans advanced, net — — — — 14,376 930 15,306 Loan payments (4,671 ) — — — — (1,079 ) (5,750 ) Converted to equity — (5,852 ) — (11,867 ) — — (17,719 ) Accrued interest 7,575 2,997 — — 265 1,124 11,961 Balance, December 31, 2021 $ 48,266 $ — $ — $ — $ 14,641 $ 7,906 $ 70,813 Loans advanced, net — — 245 — — 13,138 13,383 Loan payments (2,526 ) — — — — (130 ) (2,656 ) Converted to equity — — — — — (2,784 ) (2,784 ) Accrued interest 3,381 — — — 564 233 4,178 Balance, June 30, 2022 $ 49,121 $ — $ 245 $ — $ 15,205 $ 18,363 $ 82,934 Less current portion — — — — — (8,235 ) (8,235 ) Long-term portion $ 49,121 $ — $ 245 $ — $ 15,205 $ 10,128 $ 74,699 Convertible Notes On May 14, 2020, the Company issued $5,827 in convertible notes to existing investors in the Company. The notes pay interest of 5% per annum and have a maturity date of February 28, 2022. The notes can be converted into SVS of the Company for $0.25 per share at any time at the option of the holder. The Company was permitted to require mandatory conversion at any time that the Company’s stock price remains above $0.50 for 45 consecutive days. In 2021, the Company enacted the mandatory conversion feature and converted the May 2020 Convertible Note balance to subordinate voting shares. As part of issuing the convertible notes, the investors were given the right to exchange stock in the Company into separate convertible notes (swap notes). In total 29,448,468 shares with a value of $13,661 were exchanged for $13,661 in convertible notes. These notes were effective May 28, 2020, have a maturity date of May 28, 2025, and can be converted into Class A Subordinate Voting Shares of the Company for $0.46 per share at any time at the option of the holder. The notes pay no interest if the Company’s annual revenue is greater than $15,000, and 3% annually otherwise. The Company can require mandatory conversion at any time that the Company’s stock price remains above $0.92 for 45 consecutive days. In 2021, the Company exercised the mandatory conversion feature and converted the May 2020 Convertible Note (Swap) balance to subordinate voting shares. On October 6, 2021, the Company entered into a convertible promissory note purchase agreement for $15,000, less issuance costs of $624, resulting in net proceeds of $14,376. The notes pay interest of 6% per annum and have a maturity date of October 6, 2024. The notes can be converted into SVS of the Company for $1.03 per share at any time at the option of the holder. As of June 30, 2022, no payments have been made for this loan. LI Lending LLC On May 10, 2019, the Company entered into a loan agreement with LI Lending LLC, a related party, for $50,000. LI Lending LLC is related because an officer of the Company is a part-owner of LI Lending LLC. As of June 30, 2022, the Company had drawn $45,000 on the loan in two amounts, an initial $35,000 and a final $10,000, both bearing a 10.25% and 12.25% interest rate, respectively. The outstanding balance as of June 30, 2022 is $49,457, less debt discount of $336, for a net balance of $49,121. See Note 13 for further discussion of this related party transaction. In April 2020, the loan was amended. In exchange for consent to allow the sale of the Pennsylvania and Maryland assets and the release of related collateral, the Company agreed to make prepayments of principal to LI Lending LLC in the amount of $250 per month for an eight-month period beginning on May 1, 2020. The $2,000 prepayment was applied to the initial $35,000 amount, decreasing the balance to $33,000. Additionally, the Company agreed to pay an increased interest rate of 12.25% on the final $10,000 of the loan until such time as this amount has been paid down, with the initial $33,000 amount continuing to be subject to the original 10.25% interest rate. In December 2020, the loan was amended to allow for the release of collateral for the sale and leaseback transactions described in Note 8 above, which was entered into with Innovative Industrial Properties, Inc. (“IIPR”). The amendment increased both interest rates by 2.5% on the loan amounts but allowed the payments resulting from the incremental interest to be deferred until January 1, 2022. The Company elected to defer payment, and the additional 2.5% interest is accrued each month and added to the balance of the loan. The Company was required to make interest-only payments monthly of 10.25% on the initial $33,000 and 12.25% on the final $10,000 of the loan until January 1, 2022 when the interest rates of 12.75% for the initial $33,000 and 14.75% for the final $10,000 took effect for the remaining term. The loan matures on May 10, 2024. An exit fee of 20% of the principal balance will be due as principal is repaid. Accrued interest expense of $3,381 includes a loan discount accretion expense of $165 for the six months ended June 30, 2022. Accrued interest expense of $1,490 includes a loan discount accretion expense of $40 for the three months ended June 30, 2022. On January 1, 2022, the Company began making the required principal payments in addition to the interest payments for this loan. As of June 30, 2022, the Company has made $2,526 in payments on this loan. Other Outstanding as of June 30, 2022 were other payables totaling $18,363 which include notes issued as part of the acquisitions of Healthy Pharms, NECC, and Arkansas entities as follows: Other Subsidiary Terms June 30, 2022 December 31, 2021 Healthy Pharms Inc. Unsecured convertible note, due November 18 $ — $ 2,784 Healthy Pharms Inc. Unsecured promissory note at $0.50 per share due December 18, 2022 at 10% per annum (1) 3,377 3,213 Island Global Promissory note due October 25, 2026 at 6% per annum 10,128 — NECC Promissory note due September 12, 2022 at 10% per annum 2,084 — Om of Medicine, LLC Promissory note due September 1, 2022 at 12% per annum (3) 981 — Arkansas Entities Unsecured Promissory note due December 1, 2022, monthly interest payments at 14% per annum 1,709 1,709 Equipment Loans Secured by equipment, monthly payments beginning in 2021 at 15% per annum 63 49 Other Various 21 151 Total Notes Payable and Convertible $ 18,363 $ 7,906 (1) In November 2021, the unsecured promissory note was modified to be due and payable in full on or before December 18, 2022. The Company concluded the extension resulted in a debt modification under ASC 470 (2) In July 2022, the promissory note was modified, whereby 50% of the outstanding note payable was paid on July 28, 2022, and the remaining outstanding balance of the note was to be payable in full on or before September 12, 2022. (3) In April 2022, the Company entered into a seller note payable to pay the outstanding balance due resulting from the 2021 Om earnout in connection with prior period contingent considerations. The note bore 10% interest per annum and was due to be paid in full by July 1, 2022. At the time of the issuance of the note, the liability was current and was certain to be paid during 2022. In July 2022, the Company amended the note, whereby the Company paid $345 of the remaining balance on the seller note and the term of the remaining balance of the seller note was extended to September 1, 2022, bearing interest at 12% per annum. If payment is not received in full by September 1, 2022, the remaining balance on the note will accrue interest at 20% per Future minimum payments on the notes payable and convertible debt are as follows: June 30, 2022 2022 $ 8,235 2023 — 2024 64,326 2025 — 2026 12,874 Thereafter — Total minimum payments 85,435 Effect of discounting (2,501 ) Present value of minimum payments 82,934 Less current portion (8,235 ) Long-term portion $ 74,699 Construction Finance Liability On January 28, 2022, a wholly owned subsidiary of the Company acquired property at 29 Everett in conjunction with the NECC Merger (see Note 7 for further details on the transaction). Concurrently, effective January 28, 2022, the Company sold a portion of the property it had acquired in the acquisition for $16,000 . In connection with the sale of the property at 29 Everett, the Company agreed to lease the location back for cultivation, effective on January 28, 2022. The details of the lease included three purchase options that the Company can exercise, in which the Company has the ability to repurchase the property on either the second, fourth, or sixth anniversary of the lease agreement. The Company determined that the purchase and subsequent leasing of the land, building, and equipment at NECC was a sale of real estate, as the property and equipment sold as part of the building were interrelated with the building. Under ASC 842 - Leases The initial term of the agreement is 20 years, with two options to extend the term for five years each. The initial monthly rent payment is equal to $140 for the first year of the agreement, with 3% annual increases over the life of the agreement. As of June 30, 2022, the total finance liability associated with this transaction is $16,000 . The total interest expense incurred during the six months ended June 30, 2022 was $700.

Share Capital and Equity

Share Capital and Equity	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Share Capital and Equity	Note 10: SHARE CAPITAL AND EQUITY The Company has authorized an unlimited number of Class A Subordinate Voting Shares (“SVS”) and Class C Multiple Voting Shares (“MVS”), all with no par value. In December 2020, the shareholders of the Company passed a resolution to permit the Company to convert all Class B Subordinate Voting Shares (“PVS”) shares into Class A shares and cancel the Class B PVS equity class, which occurred in 2020. All share classes are included within share capital in the consolidated statements of stockholders’ equity on an as- as-converted Voting shares activity for the periods presented is summarized as follows: Class A Subordinate Class C Multiple Total Balance, December 31, 2020 537,575,044 1,276,208 538,851,252 Share capital issuances 55,330,352 — 55,330,352 Balance, December 31, 2021 592,905,396 1,276,208 594,181,604 Share capital issuances 43,731,290 — 43,731,290 Balance, June 30, 2022 636,636,686 1,276,208 637,912,894 Class A Subordinate Voting Shares Holders of Class A Subordinate Voting Shares are entitled to one vote in respect of each SVS. Class C Multiple Voting Shares Holders of Class C Multiple Voting Shares are entitled to 800 votes in respect of each MVS. One MVS can convert to one SVS but are not convertible until the later of the date that (i) the aggregate number of PVS and MVS held by the Initial Holders (being the MVS holders on their initial issuance) are reduced to a number which is less than 50% of the aggregate number of PVS and MVS held by the Initial Holders on the date of completion of the Business Combination with Cannex, and (ii) 3 years following the date of the business combination with Cannex. Series Shares outstanding as of As converted to SVS Class A - Subordinate Voting Shares 636,636,686 636,636,686 Class C - Multiple Voting Shares 1,276,208 1,276,208 637,912,894 637,912,894 On November 23, 2020, the Company closed a brokered private placement and issued 24,644,500 Units at a price of C$0.70 per Unit. Each Unit is comprised of one subordinate voting share of the Company and one-half Because of the Canadian dollar denominated exercise price, these warrants do not qualify to be classified within equity and are therefore classified as derivative liabilities at fair value with changes being reported through the statement of operations. On November 23, 2020, the warrants were valued using the Black Scholes option pricing model at $4,229 using the following assumptions: Share Price: C$0.94; Exercise Price: C$0.90; Expected Life: 2 years; Annualized Volatility: 87.73%; Dividend yield: 0.00%; Discount Rate: 0.16%; C$ Exchange Rate:1.31. On June 30, 2022, the warrants were revalued using the Black Scholes option pricing model, using the following assumptions: Share Price: C$0.71; Expected Life: 0.4 years; Annualized Volatility: 61.40%; Dividend yield: 0.00%; Discount Rate: 2.51%; C$ Exchange Rate: 1.29. The decrease in the value of the derivative liability of $3,074 is reflected in the statement of operations as a $3,074 gain on the change in fair value of the derivative liability.

Warrants

Warrants	6 Months Ended
	Jun. 30, 2022
Warrants and Rights Note Disclosure [Abstract]
Warrants	Note 11: WARRANTS As of June 30, 2022, there were share purchase warrants outstanding to purchase up to 29,103,553 SVS shares: Series Number of warrants Weight-average Balance, December 31, 2021 26,192,237 $ 0.75 Issued 2,999,975 1.00 Exercised (88,659 ) 0.56 Balance, June 30, 2022 29,103,553 $ 0.75 As of June 30, 2022, the Company has the following warrants outstanding: Warrants Outstanding Exercise Price Expiry Date 10,403,150 C$ 0.90 * November 23, 2022 209,426 C$ 0.70 * November 23, 2022 12,135,922 $ 0.82 * December 17, 2022 2,230,080 $ 0.67 * January 29, 2023 2,999,975 $ 1.00 April 13, 2024 625,000 C$ 0.80 * October 6, 2024 500,000 C$ 0.80 * October 6, 2025 29,103,553 * Represents warrants that are exercisable as of June 30, 2022.

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Jun. 30, 2022
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	Note 12: SHARE-BASED COMPENSATION The Company adopted two equity incentive plans where the Company may grant Class A stock options. Under the terms of the plans, the maximum number of stock options which may be granted are a total of 10% of the number of shares outstanding assuming conversion of all shares to SVS. The exercise price for stock options issued under the plans will be set by the compensation committee of the board of directors but will not be less than 100% of the fair market value of the Company’s shares on the grant date. Stock options have a maximum term of 10 years from the date of grant. Stock options vest at the discretion of the Board. As of June 30, 2022, the Company had the following options outstanding and exercisable on an as-converted Grant Date Strike Price in Outstanding Exercisable Life Remaining July 31, 2019 0.10 6,245,840 6,245,840 2.22 July 31, 2019 1.00 7,783,332 7,783,332 0.45 July 31, 2019 1.00 1,166,667 1,166,667 1.27 July 31, 2019 1.50 508,333 508,333 1.95 July 31, 2019 1.50 800,000 800,000 1.96 August 22, 2019 0.80 5,237,720 4,459,942 2.15 August 22, 2019 1.00 6,150,000 5,522,222 2.15 November 1, 2019 0.80 1,200,000 1,000,000 2.34 February 3, 2020 0.80 348,333 148,333 2.60 June 8, 2020 0.80 25,000 12,500 2.94 July 31, 2020 0.80 1,200,000 1,150,000 3.09 September 15, 2020 0.86 7,315,860 7,315,860 3.21 October 2, 2020 0.77 3,000,000 3,000,000 3.26 November 24, 2020 0.94 1,675,000 1,675,000 3.41 December 2, 2020 1.11 2,900,000 2,900,000 3.43 December 21, 2020 1.06 1,200,000 600,000 3.48 March 18, 2021 1.63 6,375,000 4,158,333 3.72 April 2, 2021 1.36 166,667 100,000 3.76 April 21, 2021 1.58 175,000 116,667 3.81 June 23, 2021 1.56 250,000 216,667 3.98 November 11, 2021 1.33 25,000 6,250 4.37 January 25, 2022 0.89 975,000 209,896 4.58 February 1, 2022 0.84 100,000 20,556 4.59 February 17, 2022 0.85 100,000 14,167 4.64 March 1, 2022 1.09 200,000 33,333 4.67 April 27, 2022 0.90 1,200,000 71,111 4.83 June 17, 2022 0.77 3,735,000 723,661 4.97 60,057,752 49,958,670 2.72 Stock option activity is summarized as follows: Number of Weighted Weighted Balance December 31, 2020 50,427,065 0.84 3.72 Granted 7,900,000 1.62 5.00 Exercised (2,737,326 ) 1.04 — Forfeited/ Expired (1,306,987 ) 0.43 — Balance December 31, 2021 54,282,752 0.94 2.97 Granted 6,435,000 0.83 5.00 Exercised (51,975 ) 0.80 — Forfeited/ Expired (608,025 ) 1.62 — Balance June 30, 2022 60,057,752 0.92 2.72 During the six months ended June 30, 2022 and 2021, the Company recognized share-based compensation of $1,428 and $5,375. During the three months ended June 30, 2022 and 2021, the Company recognized share-based compensation of $390 In determining the amount of equity-based compensation during the year, the Company used the Black-Scholes option pricing model to establish fair value of options granted during the year with the following key assumptions: 2022 2021 Risk-Free Interest Rate 2.42 % 0.87 % to 0.92% Expected Life (years) 5.00 5.00 Expected Annualized Volatility 71.30 % 86.2 % to 93.53% Forfeiture rate — % — % Expected Dividend Yield — % — %

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Parties	Note 13: RELATED PARTIES Related party transactions LI Lending LLC Linchpin Investors LLC (“Linchpin”), a subsidiary of the Company, and LI Lending LLC (“LI Lending”) entered into a Construction Loan Agreement dated May 10, 2019, as amended, whereby Linchpin received an up-to Pure Ratios Leonid Gontmakher, Chief Executive Officer of the Company, holds an interest in an entity related to iWolf Management, LLC, an online marketing company serving the online CBD market which provided online marketing services during 2020 and 2019 for the Company’s Pure Ratios division. Pure Ratios paid $313 for the three and six months ended June 30, 2021 to this vendor for management fees, pass through marketing costs and customer service. Pure Ratios did not make any such payments during the six months ended June 30, 2022. MP Illinois The Company maintains a contractual relationship with entities that are wholly owned by MP Illinois, a single-member LLC owned by Mr. Joshua N. Rosen, a former officer and director of the Company. The Company holds a nominee agreement whereby the Company receives a 100% beneficial (but not legal) interest IL Grown Medicine, LLC, the holder of a cultivation license in Illinois.

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Note 14: CONTINGENCIES (a) Cannabis Industry Cannabis is still considered a Schedule I (b) Contingent consideration payable As part of the acquisition of Om of Medicine, LLC and Cannex’s prior acquisition of Pure Ratios, the Company is subject to contingent consideration payable to the sellers. The fair value of the contingent consideration, which is based on specific revenue levels achieved over a 2-3-year Om of Balance, December 31, 2021 $ 2,393 Changes in fair value (2,393 ) Balance, June 30, 2022 — Less: current portion — Long-term portion $ — The contingent consideration payable is measured at fair value based on unobservable inputs and is considered a Level 3 financial instrument. The determination of the fair value of these liabilities is primarily driven by the Company’s expectations of the respective subsidiaries achieving certain milestones. The expected milestones were assigned probabilities and the expected related cash flows were discounted to derive the fair value of the contingent consideration. The Company reached expected milestones during the year ended December 31, 2021, which resulted in a contingent consideration payment of $ that was due to be paid by the Company in 2022. The Company paid $ of the outstanding balance in April 2022. As discussed in Note 9, in April 2022, the Company entered into a seller note to pay the outstanding balance of the liability. The term of the note expires in six months and accrues interest at 10% per annum. See Note 9 for the outstanding balance of the note payable as of June 30, 2022. The Company had an outstanding balance of contingent consideration of $2,393 for the period ended December 31, 202 1 OM of Medicine: (c) Legal Matters From time to time, the Company may be involved in certain disputes arising in the ordinary course of business. Such disputes, taken in the aggregate, are not expected to have a material adverse effect on the Company. There are also no proceedings in which any of the Company’s directors, officers, or affiliates is an adverse party or has a material interest adverse to the Company’s interest. On May 15, 2017, the Company’s wholly-owned subsidiary, 4Front Advisors, LLC, entered into an Application, Training, and Consulting Agreement with 5Seat Investment, LLC and Kanna. A dispute arose about amounts owed to the subsidiary under the agreement, and on May 17, 2022, the parties agreed to settle the matter for payment of $600 to the Company’s subsidiary. On January 26, 2022, Savills , Inc. sued the Company in the U.S. District Court for the Southern District of New York. That lawsuit alleged that the Company had breached an alleged agreement with Savills under which the Company was allegedly required to pay Savills a percentage of savings realized under certain incentive programs offered in some jurisdictions, which Savills would assist the Company in obtaining. Savills claimed damages of approximately $ in connection with its claim that it obtained benefits for the Company allegedly valued at over $ . The Company denied these allegations, denied the Company had obtained such benefits, disputed Savills’ characterization of the facts, and denied liability. The Company filed a counterclaim against Savills alleging breach of contract by Savills. On August 3, 2022, the parties reached a confidential settlement in principle and agreed to dismissal of all claims. In accordance with the order of dismissal, if no application to restore the litigation is submitted by September 6, 2022, the case will be dismissed without prejudice.

Financial Instruments and Finan

Financial Instruments and Financial Risk Management	6 Months Ended
	Jun. 30, 2022
Investments, All Other Investments [Abstract]
Financial Instruments and Financial Risk Management	Note 15: FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT ASC 820, Fair Value Measurements, provides guidance on the development and disclosure of fair value measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles in the United States of America, and expands disclosures about fair value measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories: Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and Level 3 Inputs for the asset or liability that are not based on observable market data (unobservable inputs). Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the periods ended June 30, 2022 and December 31, 2021. The fair value of the Company’s cash, accounts receivable, other receivables, accounts payable and accrued expenses approximates carrying value due to their short-term nature. The Company’s notes receivable, lease receivables, contingent consideration payable, derivative liabilities, convertible notes payable, construction finance liability and notes payable approximate fair value due to the instruments bearing market rates of interest or their short term nature. As the interest rates utilized to calculate these instruments approximates market value interest rates, the carrying amounts of the instruments approximate fair value, which are primarily based on Level 1 inputs. The fair value of stock options granted were estimated based on a Black-Scholes model during the periods ended June 30, 2022 and December 31, 2021. The estimated fair value of the derivative liabilities, which represent embedded put included in the convertible notes payable, represent Level 3 measurements. The following table details the fair value measurements within the fair value hierarchy of the Company’s financial instruments, which includes the Level 3 liabilities: Fair value at June 30, 2022 Total Level 1 Level 2 Level 3 Liabilities: Derivative liability $ 428 $ — $ — $ 428 Total liabilities $ 428 $ — $ — $ 428 Fair value at December 31, 2021 Total Level 1 Level 2 Level 3 Liabilities: Derivative liability $ 3,502 $ — $ — $ 3,502 Total liabilities $ 3,502 $ — $ — $ 3,502 The table below provides a summary of the changes in fair value of the derivative liabilities measured on a recurring basis using significant unobservable inputs (Level 3): For the Six Months Ended June 30, 2022 2021 Derivative liability: Balance, beginning of period $ 3,502 $ 5,807 (Gain) loss on fair value of derivative liability (3,074 ) 2,843 Change in fair value of derivative liability upon exercise of warrants — (1,427 ) Balance, end of period $ 428 $ 7,223 There were no transfers between fair value levels for the six months ended June 30, 2022 and the year ending December 31, 2021. (a) Financial Risk Management The Company is exposed in varying degrees to a variety of financial instruments related risks. The Board mitigates these risks by assessing, monitoring and approving the Company’s risk management processes. (b) Credit Risk Credit risk is the risk of loss associated with a counterparty’s inability to fulfill its payment obligations. The Company’s credit risk is primarily attributable to cash, lease receivables, other receivables, and notes receivable. The Company’s maximum credit risk exposure is equivalent to the carrying value of these instruments. The risk exposure is limited to the carrying amounts at the statement of financial position date. The risk to cash deposits is mitigated by holding these instruments with regulated financial institutions. Lease receivables, notes receivables and other receivables credit risk arises from the possibility that principal and interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationships. The Company maintains cash with federally insured financial institutions. As of December 31, 2021, the Company exceeded federally insured limits by approximately $10,866. The Company did not exceed any federally insured limits at any of its financial institutions for the six months ended June 30, 2022. The Company has historically not experienced any losses in such accounts. As of June 30, 2022, the Company held approximately $9 in cash in a Canadian account that is denominated in C$. As of June 30, 2022 and December 31, 2021, the maximum credit exposure related to the carrying amounts of accounts receivable, other receivable, notes receivable and lease receivables was $15,823 and $12,722, respectively. (c) Liquidity Risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations associated with financial liabilities. The Company manages liquidity risk through the management of its capital structure. The Company’s approach to managing liquidity is to raise sufficient capital to settle obligations and liabilities when due. The Company has the following obligations as of June 30, 2022, which are expected to be payable in the following respective periods: Less than 1 to 3 years 3 to 5 years Greater Total Accounts payable and accrued liabilities $ 19,422 $ 1,200 $ — $ — $ 20,622 Convertible notes, notes payable and accrued interest 8,235 74,699 — — 82,934 Contingent consideration payable — — — — — Construction finance liability — 16,000 — — 16,000 Total $ 27,657 $ 91,899 $ — $ — $ 119,556 (d) Interest Rate Risk Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. (e) Foreign Exchange Risk The Company is exposed to exchange rate fluctuations between United States and Canadian dollars. The Company’s share price is denominated in Canadian dollars. If the Canadian dollar declines against the United States dollar, the United States dollar amounts available to fund the Company through the exercise of stock options or warrants will be less. The Company also has bank accounts with balances of $9 in Canadian dollars. The value of these bank balances if converted to U.S. dollars will fluctuate. While the Company maintains a head office in Canada where it incurs expenses primarily denominated in Canadian dollars, such expenses are a small portion of overall expenses incurred by the Company. The Company does not have a practice of trading derivatives and does not engage in “natural hedging” for funds held in Canada. (f) Other Price Risk Price risk is the risk of variability in fair value due to movements in equity or market prices. The Company is subject to risk of prices to its products due to competitive or regulatory pressures.

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Segment Information	Note 16: SEGMENT INFORMATION Reportable Segments Operating segments are components of the Company that combine similar business activities, with activities grouped to facilitate the evaluation of business units and allocation of resources by the Company’s board of directors and management. As of June 30, 2022, the Company had two reportable segments: • THC Cannabis – Production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers, ancillary services supporting wholesale operations, and retail sales direct to end consumers ; and • CBD Wellness – Pure Ratios which encompasses the production and sale of CBD products to third-party customers . The results of each segment are regularly reviewed by the Company’s Chief Executive Officer, who is the Company’s chief operating decision maker, to assess the performance of the segment and make decisions regarding the allocation of resources. The Company’s chief operating decision maker uses revenue and net loss as measure of segment performance. There are no intersegment sales or transfers. All revenues are derived from customers domiciled in the United States and all assets are located in the United States. The below table presents revenues, depreciation and amortization, and net (income) loss by type for the three and six months ended June 30, 2022 and 2021, as well as assets by type as of June 30, 2022 and December 31, 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Net Revenues THC Cannabis $ 28,195 $ 26,396 $ 53,978 $ 48,544 CBD Wellness 244 725 509 1,547 Corporate — — — — Total Net Revenues 28,439 27,121 54,487 50,091 Depreciation and Amortization THC Cannabis 1,123 833 1,970 1,589 CBD Wellness — — — 16 Corporate — 28 — 30 Total Depreciation and Amortization 1,123 861 1,970 1,635 Net (Income) Loss THC Cannabis 3,846 1,003 4,102 3,841 CBD Wellness (104 ) 817 (119 ) 820 Corporate 2,809 4,403 8,467 12,651 Total Net Loss $ 6,551 $ 6,223 $ 12,450 $ 17,312 Assets June 30, 2022 December 31, 2021 THC Cannabis $ 318,795 $ 238,933 CBD Wellness 781 805 Corporate 881 15,801 Total Assets $ 320,457 $ 255,539 Goodwill assigned to the THC Cannabis segment as of June 30, 2022 and December 31, 2021 was $42,037 and $23,155, respectively. Intangible assets, net assigned to the THC Cannabis segment as of June 30, 2022 and December 31, 2021 were $54,239 and $26,246, respectively. The Company did not have any Goodwill or intangible assets assigned to the CBD Wellness segment as of June 30, 2022 and December 31, 2021.

Supplementary Cash Flow Informa

Supplementary Cash Flow Information	6 Months Ended
	Jun. 30, 2022
Supplemental Cash Flow Information [Abstract]
Supplementary Cash Flow Information	Note 17: SUPPLEMENTARY CASH FLOW INFORMATION Changes in non-cash June 30, 2022 June 30, 2021 Changes in operating assets and liabilities Accounts receivable and other receivables $ (2,766 ) $ (815 ) Inventory (5,302 ) (4,563 ) Prepaid expenses (318 ) 50 Deposits 222 (70 ) Accounts payable and accrued liabilities 4,939 65 Taxes payable 5,683 5,163 $ 2,458 $ (170 ) Supplemental disclosure of non-cash June 30, 2022 June 30, 2021 Exchange of convertible debt to equity $ 3,122 $ 17,719 Change in right-of-use $ 8 $ 153 Issuance of equity to pay contingent consideration $ — $ 883 Issuance of debt to pay contingent consideration $ — $ 485 Equity portion of warrants recorded through derivative liability $ — $ 1,427 Issuance of equity for NECC pursuant to acquisition $ 18,200 $ — Property, plant, and equipment acquired through NECC acquisition $ 15,238 $ — Issuance of notes payable through NECC acquisition $ 2,000 $ — Inventory acquired through NECC acquisition $ 213 $ — Issuance of equity for Island pursuant to acquisition $ 6,245 $ — Issuance of warrants for Island pursuant to acquisition $ 732 $ — Property and equipment acquired through Island acquisition $ 2,214 $ — ROU asset and lease liability acquired through Island acquisition $ 10,227 $ — Note payable acquired through Island acquisition $ 245 $ — Issuance of notes payable through Island acquisition $ 10,000 $ — Inventory acquired through Island acquisition $ 3,072 $ — Issuance of debt to acquire property and equipment $ 14 $ 445 Inventory acquired through issuance of note payable $ 163 $ — Cancellation of ROU asset and lease liability $ 2,020 $ — Note payable issued to satisfy accrued expenses $ 961 $ — • Cash paid for interest for the six months ended June 30, 2022 and 2021 was $3,174 and $1,662, respectively. • Cash paid for income taxes for the six months ended June 30, 2022 and 2021 was $2,100 and $224, respectively.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 18: INCOME TAXES The following table summarizes the Company’s income tax expense: For the Three Months Ended June For the Six Months Ended June 30, 2022 2021 2022 2021 Net loss before income taxes $ (3,504 ) $ (2,867 ) $ (5,960 ) $ (11,298 ) Income tax expense (3,042 ) (3,351 ) (6,480 ) (6,004 ) The Company has computed its provision for income taxes under the discrete method which treats the year-to-date pre-tax non-deductible Internal Revenue Code (“IRC”) Section 280E denies, at the U.S. federal level, deductions, and credits attributable to a trade or business trafficking in controlled substances. Because the Company is subject to IRC Section 280E, the Company has computed its U.S. tax based on gross receipts less cost of goods sold. The tax provisions for the six months ended June 30, 2022 and 2021, have been prepared based on the assumption that cost of goods sold is a valid expense for income tax purposes. The federal statute of limitation remains open for the 2018 tax year to the present. The state income tax returns generally remain open for the 2017 tax year through the present. Net operating losses arising prior to these years are also open to examination if and when utilized.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 19: SUBSEQUENT EVENTS On July 13, 2022, Kathi Lentzsch resigned from her role as Chair of the Board, while remaining a Director and Chair of the Compensation Committee, and Mr. Robert Hunt was appointed Chair of the Board.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Critical accounting estimates and judgments	(a) Critical accounting estimates and judgments Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the Company’s condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods. The significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those described in the latest annual consolidated financial statements, except for additional accounting policies identified during the interim period noted below. Contract Assets and Liabilities To the extent that the customer has paid consideration before transferring goods or services to the customer, a contract liability is recorded on the consolidated balance sheet as current portion of contract liabilities for contract liabilities due within twelve months or contract liabilities for contract liabilities due after twelve months. When the Company has an unconditional right to payment, a receivable is recorded on the consolidated balance sheet as current portion of contract assets for contract assets due within twelve months or contract assets for contract assets due after twelve months. Amounts expected to be recognized as revenue within the twelve months following the balance sheet date are classified as current portion of contract liabilities in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the twelve months following the balance sheet date are classified as contract liabilities. The accompanying condensed balance sheets reflect a contract liability for the amount of revenue to be recognized in the future as and when the Company satisfies its remaining performance obligations. As of June 30, 2022, in connection with the Island Merger, the Company had recogn ized $ of contract liabilities, $ of which were recorded as current liabilities and $ were recorded as long term liabilities. See Note 7 for further discussion on the Island Merger. We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.
Recent Accounting Pronouncements	(b) Recent Accounting Pronouncements Recently Adopted i. In August 2020, the FASB issued ASU 2020-06, 470-20) 815-40)”. 2020-06 2020-06 ii. In May 2021, the FASB issued ASU 2021-04, 815-40)”. 2021-04 2021-04 iii. In October 2021, the FASB issued ASU 2021-08, “Business Combinations—Accounting for Contract Assets and Contract Liabilities (Topic 805)”. The amendments in this update address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination by requiring that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. As a result of the amendments made by the ASU, it is expected than an acquirer will generally recognize and measure acquired contract assets and contract liabilities in a manner consistent with how the acquiree recognized and measured them in its pre-acquisition financial statements. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. An entity that early adopts in an interim period should apply the amendments (i) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (ii) prospectively to all business combinations that occur on or after the date of initial application. The Company has elected to early adopt this standard as of January 1, 2022. The adoption of the standard had an impact on the valuation of Island deferred revenue contracts upon the acquisition date. The Company recognized the contract liabilities acquired consistent with the previous accounting treatment at the acquired entity. This standard did not have an impact on the NECC acquisition entered into on January 28, 2022. Accounting Pronouncements Not Yet Adopted i. In June 2022, the FASB issued ASU 2022-03, 2022-03 2022-03

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Summary of Inventory	The Company’s inventories include the following as of June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Raw materials - unharvested cannabis $ 2,849 $ 2,164 Raw materials - harvested and purchased cannabis 10,824 3,045 Packaging and other non-finished 2,986 1,734 Work in process - manufactured and purchased extracts 4,825 4,771 Finished goods 7,353 8,373 Total $ 28,837 $ 20,087

Property Plant and Equipment (T

Property Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment and Related Depreciation	Property, plant and equipment and related depreciation are summarized in the table below: June 30, December 31, Land $ 775 $ — Buildings & improvements 13,896 1,483 Construction in process 702 63 Furniture, equipment & other 17,974 13,425 Leasehold improvements 36,878 35,538 Total $ 70,225 $ 50,509 Less: accumulated depreciation (11,258 ) (7,876 ) Total property, plant, and equipment, net $ 58,967 $ 42,633

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	Intangible assets and related amortization are summarized in the table below: Licenses Customer Non-Competition Know-How Tradenames Total Balance, December 31, 2020 $ 20,146 $ 1,668 $ 43 $ 6,933 $ — $ 28,790 Amortization expense — (580 ) (43 ) (1,921 ) — (2,544 ) Balance, December 31, 2021 $ 20,146 $ 1,088 $ — $ 5,012 $ — $ 26,246 NECC merger and 29 Everett acquisition (Note 7) 18,000 — — — — 18,000 Island merger (Note 7) 8,700 — — — 2,600 11,300 Amortization expense — (290 ) (970 ) (47 ) (1,307 ) Balance, June 30, 2022 $ 46,846 $ 798 $ — $ 4,042 $ 2,553 $ 54,239
Summary of Goodwill	Goodwill Balance, December 31, 2020 $ 23,155 Balance, December 31, 2021 $ 23,155 NECC merger and 29 Everett acquisition (Note 7) 12,547 Island merger (Note 7) 6,335 Balance, June 30, 2022 $ 42,037

Acquisitions and Business Com_2

Acquisitions and Business Combinations (Tables)	6 Months Ended
	Jun. 30, 2022
Business Acquisition [Line Items]
Summary Of Pro Forma Information	The unaudited pro forma financial information for the Company including NECC and Island for the three months ended June 30, 2022 is as follows: For the For the Three Months Ended June 30, 2022 2021 Reported Proforma Reported Proforma Revenues $ 28,439 $ 28,706 $ 27,121 $ 28,922 (Loss) income from operations (4,099 ) (5,444 ) 668 (936 ) Net loss $ (6,546 ) $ (8,932 ) $ (6,218 ) $ (8,115 ) Basic and diluted earning (loss) per share $ (0.01 ) $ (0.01 ) $ (0.01 ) $ (0.01 ) The unaudited pro forma financial information for the Company including NECC and Island for the six months ended June 30, 2022 is as follows: For the For the Six Months Ended June 30, 2022 2021 Reported Proforma Reported Proforma Revenues $ 54,487 $ 56,113 $ 50,091 $ 53,286 (Loss) income from operations (5,340 ) (9,399 ) 1,021 (2,490 ) Net loss $ (12,440 ) $ (20,817 ) $ (17,302 ) $ (20,813 ) Basic and diluted earning (loss) per share $ (0.02 ) $ (0.03 ) $ (0.02 ) $ (0.04 )
New England Cannabis Corporation Acquisition [Member]
Business Acquisition [Line Items]
Summary Of The Preliminary Purchase Price Allocation Finalized For The NECC Acquisition	The following tables present the preliminary purchase price allocation for the NECC Merger: Cash consideration $ 25,000 Seller note 2,000 Equity consideration - common stock 18,200 Total Purchase Price $ 45,200 Description Fair value Assets acquired: Cash $ 2 Inventory 213 Property, plant, and equipment 15,238 Intangible asset - licenses 18,000 Total assets acquired $ 33,453 Liabilities assumed: Accounts payable 800 Total liabilities assumed $ 800 Estimated fair value of net assets acquired $ 32,653 Estimated Goodwill $ 12,547
Island Global Holdings, Inc. [Member]
Business Acquisition [Line Items]
Summary Of The Preliminary Purchase Price Allocation Finalized For The NECC Acquisition	The following tables present the preliminary purchase price allocation for the Island Merger: Seller note $ 10,000 Equity consideration - common stock 6,245 Equity consideration - warrants 732 Total Purchase Price $ 16,977 Description Fair value Assets acquired: Cash $ 458 Accounts receivable 876 Inventory 3,072 Prepaid expenses and other current assets 424 Property and equipment, net 2,214 Operating lease - right of use asset 10,227 Intangible assets 11,300 Total assets acquired $ 28,571 Liabilities assumed: Accounts payable $ 1,356 Accrued expenses and other liabilities 2,566 Contract liabilities 3,535 Lease liabilities 10,227 Notes payable 245 Total liabilities assumed $ 17,929 Estimated fair value of net assets acquired $ 10,642 Estimated Goodwill $ 6,335

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Summary of Company's Operating Leases	The following table summarizes the Company’s operating leases: Classification - Consolidated Balance Sheet June 30, 2022 December 31, 2021 Assets Operating lease assets Operating Lease Assets $ 106,406 $ 100,519 Liabilities Current Operating Current portion of operating lease liabilities 4,121 3,629 Noncurrent Operating Operating lease liabilities 101,380 93,111 Total lease liabilities $ 105,501 $ 96,740
Summary of Maturities Lease Liabilities For Third-Party Operating Leases	Maturities of lease liabilities for third-party operating leases as of June 30, 2022 were as follows: Operating Leases 2022 $ 8,329 2023 16,987 2024 17,491 2025 17,633 2026 18,056 2027 18,076 2028 and Thereafter 234,359 Total undiscounted cash flows $ 330,931 Less discounting (225,430 ) Total lease payments $ 105,501
Summary of Changes in Lease Receivables	The following table summarizes changes in the Company’s lease receivables: June 30, 2022 December 31, 2021 Balance, beginning of the year $ 10,378 $ 11,045 Interest 1,368 2,783 Lease payments received (1,800 ) (3,450 ) Balance, end of the period $ 9,946 $ 10,378 Less current portion (3,405 ) (3,630 ) Long-term lease receivables $ 6,541 $ 6,748
Summary of Future Minimum Lease Payments (Principal and Interest) on Leases (Lessor)	Future minimum lease payments receivable (principal and interest) on the leases are as follows: Operating Leases 2022 $ 1,830 2023 1,575 2024 — 2025 — 2026 — Thereafter — Total minimum lease payments 3,405 Effect of discounting (431 ) Present value of minimum lease payments 2,974 Present value of residual value of leased property 6,972 Total lease receivable 9,946 Current portion lease receivable (3,405 ) Long-term lease receivable $ 6,541

Notes Payable and Convertible_2

Notes Payable and Convertible Notes (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Summary of Notes Payable and Convertible Notes	The Company’s notes payable and convertible notes are as follows: LI Lending, May 2020 2022 Island May 2020 October 2021 Other Total Balance, December 31, 2020 $ 45,362 $ 2,855 $ — $ 11,867 $ — $ 6,931 $ 67,015 Loans advanced, net — — — — 14,376 930 15,306 Loan payments (4,671 ) — — — — (1,079 ) (5,750 ) Converted to equity — (5,852 ) — (11,867 ) — — (17,719 ) Accrued interest 7,575 2,997 — — 265 1,124 11,961 Balance, December 31, 2021 $ 48,266 $ — $ — $ — $ 14,641 $ 7,906 $ 70,813 Loans advanced, net — — 245 — — 13,138 13,383 Loan payments (2,526 ) — — — — (130 ) (2,656 ) Converted to equity — — — — — (2,784 ) (2,784 ) Accrued interest 3,381 — — — 564 233 4,178 Balance, June 30, 2022 $ 49,121 $ — $ 245 $ — $ 15,205 $ 18,363 $ 82,934 Less current portion — — — — — (8,235 ) (8,235 ) Long-term portion $ 49,121 $ — $ 245 $ — $ 15,205 $ 10,128 $ 74,699
Summary of Convertible Debt	Outstanding as of June 30, 2022 were other payables totaling $18,363 which include notes issued as part of the acquisitions of Healthy Pharms, NECC, and Arkansas entities as follows: Other Subsidiary Terms June 30, 2022 December 31, 2021 Healthy Pharms Inc. Unsecured convertible note, due November 18 $ — $ 2,784 Healthy Pharms Inc. Unsecured promissory note at $0.50 per share due December 18, 2022 at 10% per annum (1) 3,377 3,213 Island Global Promissory note due October 25, 2026 at 6% per annum 10,128 — NECC Promissory note due September 12, 2022 at 10% per annum 2,084 — Om of Medicine, LLC Promissory note due September 1, 2022 at 12% per annum (3) 981 — Arkansas Entities Unsecured Promissory note due December 1, 2022, monthly interest payments at 14% per annum 1,709 1,709 Equipment Loans Secured by equipment, monthly payments beginning in 2021 at 15% per annum 63 49 Other Various 21 151 Total Notes Payable and Convertible $ 18,363 $ 7,906 (1) In November 2021, the unsecured promissory note was modified to be due and payable in full on or before December 18, 2022. The Company concluded the extension resulted in a debt modification under ASC 470 (2) In July 2022, the promissory note was modified, whereby 50% of the outstanding note payable was paid on July 28, 2022, and the remaining outstanding balance of the note was to be payable in full on or before September 12, 2022. (3) In April 2022, the Company entered into a seller note payable to pay the outstanding balance due resulting from the 2021 Om earnout in connection with prior period contingent considerations. The note bore 10% interest per annum and was due to be paid in full by July 1, 2022. At the time of the issuance of the note, the liability was current and was certain to be paid during 2022. In July 2022, the Company amended the note, whereby the Company paid $345 of the remaining balance on the seller note and the term of the remaining balance of the seller note was extended to September 1, 2022, bearing interest at 12% per annum. If payment is not received in full by September 1, 2022, the remaining balance on the note will accrue interest at 20% per
Summary of Future Minimum Payments of Notes and Convertible Notes	Future minimum payments on the notes payable and convertible debt are as follows: June 30, 2022 2022 $ 8,235 2023 — 2024 64,326 2025 — 2026 12,874 Thereafter — Total minimum payments 85,435 Effect of discounting (2,501 ) Present value of minimum payments 82,934 Less current portion (8,235 ) Long-term portion $ 74,699

Share Capital and Equity (Table

Share Capital and Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Summary of Share Capital and Equity	Series Shares outstanding as of As converted to SVS Class A - Subordinate Voting Shares 636,636,686 636,636,686 Class C - Multiple Voting Shares 1,276,208 1,276,208 637,912,894 637,912,894
Summary of Voting Shares Activity	Voting shares activity for the periods presented is summarized as follows: Class A Subordinate Class C Multiple Total Balance, December 31, 2020 537,575,044 1,276,208 538,851,252 Share capital issuances 55,330,352 — 55,330,352 Balance, December 31, 2021 592,905,396 1,276,208 594,181,604 Share capital issuances 43,731,290 — 43,731,290 Balance, June 30, 2022 636,636,686 1,276,208 637,912,894

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Jun. 30, 2022
Warrants and Rights Note Disclosure [Abstract]
Summary of Warrants Outstanding to Purchase Shares	As of June 30, 2022, there were share purchase warrants outstanding to purchase up to 29,103,553 SVS shares: Series Number of warrants Weight-average Balance, December 31, 2021 26,192,237 $ 0.75 Issued 2,999,975 1.00 Exercised (88,659 ) 0.56 Balance, June 30, 2022 29,103,553 $ 0.75
Summary of Warrants Outstanding And Exercisable	As of June 30, 2022, the Company has the following warrants outstanding: Warrants Outstanding Exercise Price Expiry Date 10,403,150 C$ 0.90 * November 23, 2022 209,426 C$ 0.70 * November 23, 2022 12,135,922 $ 0.82 * December 17, 2022 2,230,080 $ 0.67 * January 29, 2023 2,999,975 $ 1.00 April 13, 2024 625,000 C$ 0.80 * October 6, 2024 500,000 C$ 0.80 * October 6, 2025 29,103,553 * Represents warrants that are exercisable as of June 30, 2022.

Share-Based Compensation (Table

Share-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2022
Summary of Options Outstanding and Exercisable on an As-Converted Basis	As of June 30, 2022, the Company had the following options outstanding and exercisable on an as-converted Grant Date Strike Price in Outstanding Exercisable Life Remaining July 31, 2019 0.10 6,245,840 6,245,840 2.22 July 31, 2019 1.00 7,783,332 7,783,332 0.45 July 31, 2019 1.00 1,166,667 1,166,667 1.27 July 31, 2019 1.50 508,333 508,333 1.95 July 31, 2019 1.50 800,000 800,000 1.96 August 22, 2019 0.80 5,237,720 4,459,942 2.15 August 22, 2019 1.00 6,150,000 5,522,222 2.15 November 1, 2019 0.80 1,200,000 1,000,000 2.34 February 3, 2020 0.80 348,333 148,333 2.60 June 8, 2020 0.80 25,000 12,500 2.94 July 31, 2020 0.80 1,200,000 1,150,000 3.09 September 15, 2020 0.86 7,315,860 7,315,860 3.21 October 2, 2020 0.77 3,000,000 3,000,000 3.26 November 24, 2020 0.94 1,675,000 1,675,000 3.41 December 2, 2020 1.11 2,900,000 2,900,000 3.43 December 21, 2020 1.06 1,200,000 600,000 3.48 March 18, 2021 1.63 6,375,000 4,158,333 3.72 April 2, 2021 1.36 166,667 100,000 3.76 April 21, 2021 1.58 175,000 116,667 3.81 June 23, 2021 1.56 250,000 216,667 3.98 November 11, 2021 1.33 25,000 6,250 4.37 January 25, 2022 0.89 975,000 209,896 4.58 February 1, 2022 0.84 100,000 20,556 4.59 February 17, 2022 0.85 100,000 14,167 4.64 March 1, 2022 1.09 200,000 33,333 4.67 April 27, 2022 0.90 1,200,000 71,111 4.83 June 17, 2022 0.77 3,735,000 723,661 4.97 60,057,752 49,958,670 2.72
Summary of Stock Option Activity	Stock option activity is summarized as follows: Number of Weighted Weighted Balance December 31, 2020 50,427,065 0.84 3.72 Granted 7,900,000 1.62 5.00 Exercised (2,737,326 ) 1.04 — Forfeited/ Expired (1,306,987 ) 0.43 — Balance December 31, 2021 54,282,752 0.94 2.97 Granted 6,435,000 0.83 5.00 Exercised (51,975 ) 0.80 — Forfeited/ Expired (608,025 ) 1.62 — Balance June 30, 2022 60,057,752 0.92 2.72
4Front Holdings LLC
Summary of Stock Options Values using Black-Scholes Model with Key Assumptions	In determining the amount of equity-based compensation during the year, the Company used the Black-Scholes option pricing model to establish fair value of options granted during the year with the following key assumptions: 2022 2021 Risk-Free Interest Rate 2.42 % 0.87 % to 0.92% Expected Life (years) 5.00 5.00 Expected Annualized Volatility 71.30 % 86.2 % to 93.53% Forfeiture rate — % — % Expected Dividend Yield — % — %

Contingencies (Tables)

Contingencies (Tables)	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Fair Value of Contingent Consideration	The fair value of the contingent consideration, which is based on specific revenue levels achieved over a 2-3-year Om of Balance, December 31, 2021 $ 2,393 Changes in fair value (2,393 ) Balance, June 30, 2022 — Less: current portion — Long-term portion $ —

Financial Instruments and Fin_2

Financial Instruments and Financial Risk Management (Tables)	6 Months Ended
	Jun. 30, 2022
Investments, All Other Investments [Abstract]
Schedule of Gross Contractual Obligations	The Company has the following obligations as of June 30, 2022, which are expected to be payable in the following respective periods: Less than 1 to 3 years 3 to 5 years Greater Total Accounts payable and accrued liabilities $ 19,422 $ 1,200 $ — $ — $ 20,622 Convertible notes, notes payable and accrued interest 8,235 74,699 — — 82,934 Contingent consideration payable — — — — — Construction finance liability — 16,000 — — 16,000 Total $ 27,657 $ 91,899 $ — $ — $ 119,556
Schedule of Fair Value Measurements With in the Fair Value Hierarchy of The Financial Instruments	The following table details the fair value measurements within the fair value hierarchy of the Company’s financial instruments, which includes the Level 3 liabilities: Fair value at June 30, 2022 Total Level 1 Level 2 Level 3 Liabilities: Derivative liability $ 428 $ — $ — $ 428 Total liabilities $ 428 $ — $ — $ 428 Fair value at December 31, 2021 Total Level 1 Level 2 Level 3 Liabilities: Derivative liability $ 3,502 $ — $ — $ 3,502 Total liabilities $ 3,502 $ — $ — $ 3,502
Summary of Changes in Fair Value of the Derivative Liabilities Measured on a Recurring Basis	The table below provides a summary of the changes in fair value of the derivative liabilities measured on a recurring basis using significant unobservable inputs (Level 3): For the Six Months Ended June 30, 2022 2021 Derivative liability: Balance, beginning of period $ 3,502 $ 5,807 (Gain) loss on fair value of derivative liability (3,074 ) 2,843 Change in fair value of derivative liability upon exercise of warrants — (1,427 ) Balance, end of period $ 428 $ 7,223

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Summary of Revenue By Type	The below table presents revenues, depreciation and amortization, and net (income) loss by type for the three and six months ended June 30, 2022 and 2021, as well as assets by type as of June 30, 2022 and December 31, 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Net Revenues THC Cannabis $ 28,195 $ 26,396 $ 53,978 $ 48,544 CBD Wellness 244 725 509 1,547 Corporate — — — — Total Net Revenues 28,439 27,121 54,487 50,091 Depreciation and Amortization THC Cannabis 1,123 833 1,970 1,589 CBD Wellness — — — 16 Corporate — 28 — 30 Total Depreciation and Amortization 1,123 861 1,970 1,635 Net (Income) Loss THC Cannabis 3,846 1,003 4,102 3,841 CBD Wellness (104 ) 817 (119 ) 820 Corporate 2,809 4,403 8,467 12,651 Total Net Loss $ 6,551 $ 6,223 $ 12,450 $ 17,312 Assets June 30, 2022 December 31, 2021 THC Cannabis $ 318,795 $ 238,933 CBD Wellness 781 805 Corporate 881 15,801 Total Assets $ 320,457 $ 255,539

Supplementary Cash Flow Infor_2

Supplementary Cash Flow Information (Tables)	6 Months Ended
	Jun. 30, 2022
Supplemental Cash Flow Information [Abstract]
Summary of Changes in Non-Cash Working Capital	Changes in non-cash June 30, 2022 June 30, 2021 Changes in operating assets and liabilities Accounts receivable and other receivables $ (2,766 ) $ (815 ) Inventory (5,302 ) (4,563 ) Prepaid expenses (318 ) 50 Deposits 222 (70 ) Accounts payable and accrued liabilities 4,939 65 Taxes payable 5,683 5,163 $ 2,458 $ (170 )
Summary of of non-cash investing and financing activities	Supplemental disclosure of non-cash June 30, 2022 June 30, 2021 Exchange of convertible debt to equity $ 3,122 $ 17,719 Change in right-of-use $ 8 $ 153 Issuance of equity to pay contingent consideration $ — $ 883 Issuance of debt to pay contingent consideration $ — $ 485 Equity portion of warrants recorded through derivative liability $ — $ 1,427 Issuance of equity for NECC pursuant to acquisition $ 18,200 $ — Property, plant, and equipment acquired through NECC acquisition $ 15,238 $ — Issuance of notes payable through NECC acquisition $ 2,000 $ — Inventory acquired through NECC acquisition $ 213 $ — Issuance of equity for Island pursuant to acquisition $ 6,245 $ — Issuance of warrants for Island pursuant to acquisition $ 732 $ — Property and equipment acquired through Island acquisition $ 2,214 $ — ROU asset and lease liability acquired through Island acquisition $ 10,227 $ — Note payable acquired through Island acquisition $ 245 $ — Issuance of notes payable through Island acquisition $ 10,000 $ — Inventory acquired through Island acquisition $ 3,072 $ — Issuance of debt to acquire property and equipment $ 14 $ 445 Inventory acquired through issuance of note payable $ 163 $ — Cancellation of ROU asset and lease liability $ 2,020 $ — Note payable issued to satisfy accrued expenses $ 961 $ —

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Summary of Income Tax Expense and Effective Tax Rates	The following table summarizes the Company’s income tax expense: For the Three Months Ended June For the Six Months Ended June 30, 2022 2021 2022 2021 Net loss before income taxes $ (3,504 ) $ (2,867 ) $ (5,960 ) $ (11,298 ) Income tax expense (3,042 ) (3,351 ) (6,480 ) (6,004 )

Nature of Operations - Addition

Nature of Operations - Additional Information (Details)	6 Months Ended
	Jun. 30, 2022
Nature Of Operations [Line Items]
Number of operating segments	2
Number of dispensaries	6
Massachusetts
Nature Of Operations [Line Items]
Number of production facilities	3
Illinois
Nature Of Operations [Line Items]
Number of production facilities	3

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Summary Of Significant Accounting Policies [Line Items]
Contract Liabilities	$ 3,535
Current Liabilities	1,535	$ 0
Long term liabilities	$ 2,000	$ 0

Inventory - Summary of Inventor

Inventory - Summary of Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Inventory [Line Items]
Packaging and other non-finished goods	$ 2,986	$ 1,734
Finished goods	7,353	8,373
Total	28,837	20,087
Unharvested Cannabis
Inventory [Line Items]
Raw materials - harvested and purchased cannabis	2,849	2,164
Harvested and purchased cannabis
Inventory [Line Items]
Raw materials - harvested and purchased cannabis	10,824	3,045
Manufactured and purchased extracts
Inventory [Line Items]
Work in process - manufactured and purchased extracts	$ 4,825	$ 4,771

Property Plant and Equipment -

Property Plant and Equipment - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Apr. 25, 2022	Jan. 28, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, pledged as security	$ 33,000		$ 33,000
Contractual commitments for future capital expenditures	0		0				$ 0
Depreciation expense	2,217	$ 675	3,382	$ 1,138
New England Cannabis Corporation (NECC)
Property, Plant and Equipment [Line Items]
Total amount of property plant and equipment acquired in business combination						$ 15,238
Island Global Holdings, Inc.
Property, Plant and Equipment [Line Items]
Total amount of property plant and equipment acquired in business combination	2,214		2,214		$ 2,214
Cost of Sales [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 1,771	$ 400	$ 2,719	$ 725

Property Plant and Equipment _2

Property Plant and Equipment - Summary of Property and Equipment and Related Depreciation (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 70,225	$ 50,509
Less: accumulated depreciation	(11,258)	(7,876)
Total property, plant, and equipment, net	58,967	42,633
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	775	0
Buildings & improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,896	1,483
Construction in process
Property, Plant and Equipment [Line Items]
Property and equipment, gross	702	63
Furniture, equipment & other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	17,974	13,425
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 36,878	$ 35,538

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Intangible Assets (Details) - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
	Apr. 25, 2022	Jun. 30, 2022	Dec. 31, 2021
Finite Lived Intangible Assets [Line Items]
Balance		$ 26,246	$ 28,790
Amortization expense		(1,307)	(2,544)
NECC merger and 29 Everett acquisition (Note 7)		18,000
Island merger (Note 7)		18,000
Balance		54,239	26,246
Island Global Holdings, Inc [Member]
Finite Lived Intangible Assets [Line Items]
NECC merger and 29 Everett acquisition (Note 7)		11,300
Island merger (Note 7)		11,300
Licenses
Finite Lived Intangible Assets [Line Items]
Balance		20,146	20,146
NECC merger and 29 Everett acquisition (Note 7)		18,000
Island merger (Note 7)		18,000
Balance		46,846	20,146
Licenses | Island Global Holdings, Inc [Member]
Finite Lived Intangible Assets [Line Items]
NECC merger and 29 Everett acquisition (Note 7)		8,700
Island merger (Note 7)		8,700
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Balance		1,088	1,668
Amortization expense		(290)	(580)
Balance		798	1,088
Non-competition Agreement
Finite Lived Intangible Assets [Line Items]
Balance		0	43
Amortization expense			(43)
Balance		0	0
Trademarks
Finite Lived Intangible Assets [Line Items]
Balance		0	0
Amortization expense		(47)	0
NECC merger and 29 Everett acquisition (Note 7)	$ 2,600
Island merger (Note 7)	$ 2,600
Balance		2,553	0
Trademarks | Island Global Holdings, Inc [Member]
Finite Lived Intangible Assets [Line Items]
NECC merger and 29 Everett acquisition (Note 7)		2,600
Island merger (Note 7)		2,600
Know-how (trade secrets)
Finite Lived Intangible Assets [Line Items]
Balance		5,012	6,933
Amortization expense		(970)	(1,921)
Balance		$ 4,042	$ 5,012

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Summary of Goodwill (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Goodwill [Line Items]
Balance	$ 23,155
Balance	42,037
New England Cannabis Corporation And 29 Everett Acquisition [Member]
Goodwill [Line Items]
NECC merger and 29 Everett acquisition (Note 7)	12,547
Island merger (Note 7)	12,547
Island Global Holdings, Inc [Member]
Goodwill [Line Items]
NECC merger and 29 Everett acquisition (Note 7)	6,335
Island merger (Note 7)	$ 6,335

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Thousands			6 Months Ended
	Apr. 25, 2022	Jan. 28, 2022	Jun. 30, 2022	Dec. 31, 2021
Disclosure Of Intangible Assets And Goodwill [Line Items]
Goodwill impairment			$ 0
Accumulated impairment			13,400	$ 13,400
Licenses acquired			18,000
New England Cannabis Corporation And 29 Everett Acquisition [Member]
Disclosure Of Intangible Assets And Goodwill [Line Items]
Goodwill acquired			$ 12,547
Business combination consideration amount		$ 16,977
Licenses acquired		8,700
Island Global Holdings, Inc. [Member]
Disclosure Of Intangible Assets And Goodwill [Line Items]
Goodwill acquired		$ 12,547
Business combination consideration amount	$ 45,200
Licenses acquired	18,000
Trademarks
Disclosure Of Intangible Assets And Goodwill [Line Items]
Licenses acquired	2,600
Goodwill [Member]
Disclosure Of Intangible Assets And Goodwill [Line Items]
Licenses acquired	$ 6,335

Acquisitions and Business Com_3

Acquisitions and Business Combinations - Summary Of The Preliminary Purchase Price Allocation Finalized For The NECC Acquisition (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Apr. 25, 2022
New England Cannabis Corporation Acquisition [Member]
Business Acquisition [Line Items]
Cash consideration	$ 25,000
Seller note	2,000
Equity consideration - common stock	18,200
Total Purchase Price	45,200
Assets acquired:
Cash	2
Inventory	213
Property, plant, and equipment	15,238
Intangible asset - licenses	18,000
Total assets acquired	33,453
Liabilities assumed:
Accounts payable	800
Total liabilities assumed	800
Estimated fair value of net assets acquired	32,653
Estimated Goodwill	12,547
Island Global Holdings, Inc. [Member]
Business Acquisition [Line Items]
Seller note	10,000
Equity consideration - common stock	6,245
Equity consideration - warrants	732
Total Purchase Price	16,977
Assets acquired:
Cash	458
Inventory	3,072
Accounts receivable	876
Prepaid expenses and other current assets	424
Property, plant, and equipment	2,214	$ 2,214
Operating lease - right of use asset	10,227
Intangible assets	11,300
Total assets acquired	28,571
Liabilities assumed:
Accounts payable	1,356
Accrued expenses and other liabilities	2,566
Contract liabilities	3,535
Lease liabilities	10,227
Notes payable	245
Total liabilities assumed	17,929
Estimated fair value of net assets acquired	10,642
Estimated Goodwill	$ 6,335

Acquisitions and Business Com_4

Acquisitions and Business Combinations - Summary Of Pro Forma Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Reported New England Cannabis Corporation Acquisition and Island Global Holdings Inc [Member]
Revenues	$ 28,439	$ 27,121	$ 54,487	$ 50,091
(Loss) income from operations	(4,099)	668	(5,340)	1,021
Net loss	$ (6,546)	$ (6,218)	$ (12,440)	$ (17,302)
Basic and diluted earning (loss) per share	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Proforma New England Cannabis Corporation Acquisition and Island Global Holdings Inc [Member]
Revenues	$ 28,706	$ 28,922	$ 56,113	$ 53,286
(Loss) income from operations	(5,444)	(936)	(9,399)	(2,490)
Net loss	$ (8,932)	$ (8,115)	$ (20,817)	$ (20,813)
Basic and diluted earning (loss) per share	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.04)

Acquisitions And Business Com_5

Acquisitions And Business Combinations - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands			6 Months Ended
	Apr. 25, 2022	Jan. 28, 2022	Jun. 30, 2022
Merger Agreement [Member] | Letter of Credit [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Line of credit	$ 1,000,000
Subordinate Voting Share [Member] | Merger Agreement [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Business combination consideration transferred liabilities incurred	$ 6,500,000
New England Cannabis Corporation [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Cash		$ 9,000,000
Measurement Period			1 year
Restructuring cost			$ 130
Transaction cost			$ 544
New England Cannabis Corporation [Member] | Purchase Agreement [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Percentage of voting interests acquired		100%
New England Cannabis Corporation [Member] | Business Acquistion First Amendment Agreement [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Cash		$ 16,000,000
New England Cannabis Corporation [Member] | Business Acquistion First Amendment Agreement [Member] | Convertible Debt One Issued [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Business combination consideration transferred liabilities incurred		$ 2,000,000
Short term debt fixed interest rate percentage		10%
Debt instrument, maturity date		6 months
New England Cannabis Corporation [Member] | Subordinate Voting Share [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Number of shares issued as a settlement of consideration		28,571,428
New England Cannabis Corporation [Member] | Subordinate Voting Share [Member] | Merger Agreement [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Number of shares issued as a settlement of consideration	8,783,716
Short term debt fixed interest rate percentage	6%
Debt instrument, maturity date	54 months
Warrants to purchase	$ 2,999,975
Warrants purchase price per share	$ 1
Island Global Holdings, Inc. [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Measurement Period			1 year
Restructuring cost			$ 1,288
Transaction cost			$ 47

Leases - Summary of Company's O

Leases - Summary of Company's Operating Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Assets
Operating lease assets	$ 106,406	$ 100,519
Liabilities
Current portion of operating lease liabilities	4,121	3,629
Non-current portion of operating lease liabilities	101,380	93,111
Total lease payments	$ 105,501	$ 96,740

Leases - Summary of Maturities

Leases - Summary of Maturities Lease Liabilities For Third-Party Operating Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Leases [Abstract]
2022	$ 8,329
2023	16,987
2024	17,491
2025	17,633
2026	18,056
2027	18,076
2028 and Thereafter	234,359
Total undiscounted cash flows	330,931
Less discounting	(225,430)
Total lease payments	$ 105,501	$ 96,740

Leases - Summary of Changes in

Leases - Summary of Changes in Lease Receivables (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Leases [Abstract]
Balance, beginning of the year	$ 10,378	$ 11,045
Interest	1,368	2,783
Lease payments received	(1,800)	(3,450)
Balance, end of the period	9,946	10,378
Less current portion	(3,405)	(3,630)
Long-term lease receivables	$ 6,541	$ 6,748

Leases - Summary of Future Mini

Leases - Summary of Future Minimum Lease Payments (Principal and Interest) on Leases (Lessor) (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2022	$ 1,830
2023	1,575
2024
2025
2026
Thereafter
Total minimum lease payments	3,405
Effect of discounting	(431)
Present value of minimum lease payments	2,974
Present value of residual value of leased property	6,972
Total lease receivable	9,946	$ 10,378	$ 11,045
Current portion of lease receivables	(3,405)	(3,630)
Long-term lease receivable	$ 6,541	$ 6,748

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Leases [Line Items]
Operating lease expense	$ 2,595	$ 2,400	$ 7,417	$ 4,868
Real estate income	2,951	2,669	5,916	5,559
Lease incentive receivable, Noncurrent	6,541		6,541		$ 6,748
Lease incentive receivable, Current	3,405		3,405		$ 3,630
Elma, Building
Leases [Line Items]
Real estate income	676	570	1,368	1,361
Olympia Building
Leases [Line Items]
Real estate income	$ 2,275	$ 2,099	$ 4,548	$ 4,198
Minimum
Leases [Line Items]
Lessee incremental borrowing rate percentage			10.25%	10.25%
Lessee, Operating Lease, Remaining lease term	1 year		1 year
Maximum
Leases [Line Items]
Lessee incremental borrowing rate percentage			18%	17%
Lessee, Operating Lease, Remaining lease term	19 years 2 months 12 days		19 years 2 months 12 days

Notes Payable and Convertible_3

Notes Payable and Convertible Notes - Summary of Notes Payable and Convertible Notes (Details) - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
	Oct. 06, 2021	Jun. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Beginning Balance		$ 70,813	$ 67,015
Loans advanced, net		13,383	15,306
Loan payments		(2,656)	(5,750)
Converted to equity		(2,784)	(17,719)
Accrued interest		4,178	11,961
Less current portion		(8,235)
Long-term portion		74,699
Ending Balance		82,934	70,813
LI Lending, LLC
Debt Instrument [Line Items]
Beginning Balance		48,266	45,362
Loans advanced, net			0
Loan payments		(2,526)	(4,671)
Accrued interest		3,381	7,575
Long-term portion		49,121
Ending Balance		49,121	48,266
May 2020 Convertible Notes
Debt Instrument [Line Items]
Beginning Balance		0	2,855
Loan payments		0	0
Converted to equity			(5,852)
Accrued interest		0	2,997
Long-term portion		0
Ending Balance		0	0
May 2020 Convertible Notes (Swap)
Debt Instrument [Line Items]
Beginning Balance		0	11,867
Loans advanced, net			0
Converted to equity		0	(11,867)
Accrued interest		0	0
Long-term portion		0
Ending Balance		0	0
October 2021 Convertible Note
Debt Instrument [Line Items]
Beginning Balance		14,641
Loans advanced, net	$ 14,376	0	14,376
Loan payments	$ 0	0	0
Converted to equity		0
Accrued interest		564	265
Less current portion		0
Long-term portion		15,205
Ending Balance		15,205	14,641
2022 Island Global Holdings Related Party Notes
Debt Instrument [Line Items]
Beginning Balance		0	0
Loans advanced, net		245	0
Converted to equity		0	0
Accrued interest		0	0
Long-term portion		245
Ending Balance		245	0
Other Loans
Debt Instrument [Line Items]
Beginning Balance		7,906	6,931
Loans advanced, net		13,138	930
Loan payments		(130)	(1,079)
Converted to equity		(2,784)	0
Accrued interest		233	1,124
Less current portion		(8,235)
Long-term portion		10,128
Ending Balance		$ 18,363	$ 7,906

Notes Payable and Convertible_4

Notes Payable and Convertible Notes - Additional Information (Details) $ / shares in Units, $ in Thousands							1 Months Ended			3 Months Ended	6 Months Ended	12 Months Ended
	Jan. 28, 2022 USD ($)	Jan. 01, 2022 USD ($)	Oct. 06, 2021 USD ($) $ / shares	May 28, 2020 USD ($) shares $ / shares	May 14, 2020 USD ($) shares $ / shares	Apr. 30, 2020 USD ($)	Jul. 31, 2022 USD ($)	Apr. 30, 2022	Nov. 30, 2021	Jun. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 01, 2022	May 10, 2019 USD ($)
Debt Instrument [Line Items]
Issuance of notes payable											$ 13,383	$ 15,306
Interest rate, stated percentage								10%							20%
Other payables										$ 18,363	18,363
Repayments of Debt											2,656	5,750
Long term debt, Gross										85,435	85,435
Long-term Debt										$ 82,934	$ 82,934	70,813	$ 67,015
Interest payable												1,490
Debt instrument, Maturity date range, End								Sep. 01, 2022	Dec. 18, 2022
Acquired property sold	$ 16,000,000
Finance lease term										20 years	20 years
Finance Lease Option To Extend											two options to extend the term for five years each.
Lease extend Term										5 years	5 years
Initial rent payments											$ 140
Finance Lease Payment Terms And Conditions											3% annual increases over the life of the agreement
Finance liability										$ 16,000	$ 16,000
Interest expense											700
LI Lending, LLC
Debt Instrument [Line Items]
Issuance of notes payable												0
Maximum borrowing capacity under credit facility																$ 50,000
Amount drawn under credit facility											45,000
Debt instrument, monthly interest-only payments	$ 33,000	$ 33,000				$ 33,000					35,000		33,000	$ 35,000
Debt instrument, final interest-only payments		$ 10,000				10,000					$ 10,000		$ 10,000
Agreed prepayment principal for month						$ 250
Principal amount prepayment period						8 months
Additional Interest rate on final loan amount						12.25%
Debt prepayment						$ 2,000
Increase in interest rate													2.50%
Interest rate on initial loan amount		12.75%				10.25%				10.25%	10.25%		10.25%
Interest rate on final loan amount		14.75%								12.25%	12.25%		12.25%
Percentage of exit fee of the principal balance											20%
Repayments of Debt											$ 2,526	4,671
Long term debt, Gross										$ 49,457	49,457
Debt instrument, Unamortized discount										336	336
Long-term Debt										49,121	49,121	48,266	$ 45,362
Interest payable										3,381	3,381
Loan discount accretion expense										40	165
October 2021 Convertible Note
Debt Instrument [Line Items]
Issuance of notes payable			$ 14,376								0	14,376
Interest rate, stated percentage			6%
Debt instrument, maturity date			Oct. 06, 2024
Debt instrument, convertible, conversion price | $ / shares			$ 1.03
Seller note outstanding			$ 15,000
Payments of debt issuance costs			624
Repayments of Debt			$ 0								0	0
Long-term Debt										$ 15,205	$ 15,205	$ 14,641
Convertible Note
Debt Instrument [Line Items]
Issuance of notes payable					$ 5,827
Interest rate, stated percentage					5%
Debt instrument, issuance date					May 14, 2020
Debt instrument, maturity date					Feb. 28, 2022
Debt instrument, convertible, conversion price | $ / shares					$ 0.25
Debt instrument, convertible, stock price trigger | $ / shares					$ 0.5
Debt instrument, convertible, threshold consecutive trading days | shares					45
Convertible Notes (Swap)
Debt Instrument [Line Items]
Debt instrument, maturity date				May 28, 2025
Debt instrument, convertible, conversion price | $ / shares				$ 0.46
Debt instrument, convertible, stock price trigger | $ / shares				$ 0.92
Debt instrument, convertible, threshold consecutive trading days | shares				45
Number of shares exchanged in debt | shares				29,448,468
Issued debt in exchange of convertible equity				$ 13,661
Exchanged shares value				$ 13,661
Debt instrument, interest rate terms				The notes pay no interest if the Company’s annual revenue is greater than $15,000, and 3% annually otherwise.
Minimum required annual revenue for interest payment				$ 15,000
Minimum required percentage of annual revenue for interest payment				3%
Promissory Note [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date							Jul. 28, 2022
Debt instrument, Maturity date range, End							Sep. 12, 2022
Outstanding Percentage Of Note Payable							50%
Seller Note
Debt Instrument [Line Items]
Debt instrument, Maturity date range, End								Jul. 01, 2022
Seller Note | Subsequent Event [Member]
Debt Instrument [Line Items]
Interest rate, stated percentage							12%
Debt instrument, maturity date							Sep. 01, 2022
Seller note outstanding							$ 345

Notes Payable and Convertible_5

Notes Payable and Convertible Notes - Summary of Convertible Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Total Notes Payable and Convertible Notes	$ 18,363	$ 7,906
Healthy Pharms Inc. | Convertible Note
Debt Instrument [Line Items]
Terms	Unsecured convertible note, due November 18, 2021 at 12% per annum
Total Notes Payable and Convertible Notes	$ 0	2,784
Healthy Pharms Inc. | Unsecured Debt
Debt Instrument [Line Items]
Terms	Unsecured promissory note at $0.50 per share due December 18, 2022 at 10% per annum (1)
Total Notes Payable and Convertible Notes	$ 3,377	3,213
Om of Medicine, LLC | Promissory Note [Member] | 12% Promissory Note [Member]
Debt Instrument [Line Items]
Terms	Promissory note due September 1, 2022 at 12% per annum (3)
Total Notes Payable and Convertible Notes	$ 981	0
Arkansas Entities | Unsecured Debt | 14% Unsecured Promissory Note
Debt Instrument [Line Items]
Terms	Unsecured Promissory note due December 1, 2022, monthly interest payments at 14% per annum
Total Notes Payable and Convertible Notes	$ 1,709	1,709
Equipment Loans | Secured Debt
Debt Instrument [Line Items]
Terms	Secured by equipment, monthly payments beginning in 2021 at 15% per annum
Total Notes Payable and Convertible Notes	$ 63	49
Other
Debt Instrument [Line Items]
Terms	Various
Total Notes Payable and Convertible Notes	$ 21	151
NECC | Notes Payable, Other Payables
Debt Instrument [Line Items]
Terms	Promissory note due September 12, 2022 at 10% per annum
Total Notes Payable and Convertible Notes	$ 2,084	0
Island Global Holdings, Inc. [Member] | Notes Payable, Other Payables
Debt Instrument [Line Items]
Terms	Promissory note due October 25, 2026 at 6% per annum
Total Notes Payable and Convertible Notes	$ 10,128	$ 0

Notes Payable and Convertible_6

Notes Payable and Convertible Notes - Summary of Convertible Debt (Parenthetical) (Details) - $ / shares		1 Months Ended		6 Months Ended	12 Months Ended
	May 14, 2020	Apr. 30, 2022	Nov. 30, 2021	Jun. 30, 2022	Dec. 31, 2021	Sep. 01, 2022
Debt Instrument [Line Items]
Interest rate, stated percentage		10%				20%
Debt instrument, Maturity date range, End		Sep. 01, 2022	Dec. 18, 2022
Convertible Note
Debt Instrument [Line Items]
Debt instrument, convertible, conversion price	$ 0.25
Interest rate, stated percentage	5%
Debt instrument, maturity date	Feb. 28, 2022
Healthy Pharms Inc. | Convertible Note
Debt Instrument [Line Items]
Debt instrument, maturity date				Nov. 18, 2021	Nov. 18, 2021
Percentage of paid in kind interest rate				12%	12%
Healthy Pharms Inc. | Unsecured Debt
Debt Instrument [Line Items]
Debt instrument, convertible, conversion price				$ 0.5	$ 0.5
Interest rate, stated percentage				10%	10%
Debt instrument, maturity date				Dec. 18, 2022	Dec. 18, 2022
Om of Medicine, LLC | Promissory Note [Member] | 12% Promissory Note [Member]
Debt Instrument [Line Items]
Interest rate, stated percentage				12%
Debt instrument, maturity date				Sep. 01, 2022
Arkansas Entities | Unsecured Debt
Debt Instrument [Line Items]
Interest rate, stated percentage				14%	14%
Equipment Loans | Secured Debt
Debt Instrument [Line Items]
Interest rate, stated percentage				15%	15%
Debt monthly payment beginning year				2021	2021
New England Cannabis Corporation (NECC) | Notes Payable, Other Payables
Debt Instrument [Line Items]
Interest rate, stated percentage				10%	10%
Debt instrument, maturity date				Sep. 12, 2022
Island Global Holdings, Inc. [Member] | Notes Payable, Other Payables
Debt Instrument [Line Items]
Interest rate, stated percentage				6%	6%
Debt instrument, maturity date				Oct. 25, 2026	Oct. 25, 2026

Notes Payable and Convertible_7

Notes Payable and Convertible Notes - Summary of Future Minimum Payments of Notes and Convertible Notes (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
2022	$ 8,235
2023	0
2024	64,326
2025	0
2026	12,874
Thereafter	0
Total minimum payments	85,435
Effect of discounting	(2,501)
Present value of minimum payments	82,934	$ 70,813	$ 67,015
Less current portion	(8,235)
Long term portion	$ 74,699

Share Capital and Equity - Addi

Share Capital and Equity - Additional Information (Details) $ in Thousands		3 Months Ended		6 Months Ended		12 Months Ended
	Nov. 23, 2020 USD ($) shares	Jun. 30, 2022 USD ($) $ / shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Dec. 31, 2021 shares	Nov. 23, 2020 $ / shares
Class Of Stock [Line Items]
Period when the convertibility of shares from one class to another become exercisable				3 years
Units issued | shares				43,731,290		55,330,352
Change in fair value of derivative liability | $		$ 1,774	$ (311)	$ 3,074	$ (2,843)
Option Pricing Model
Class Of Stock [Line Items]
Warrants classified as derivative liability value | $	$ 4,229
Warrants measurement input							0.94
Expected Life	2 years
Option Pricing Model | Share Price
Class Of Stock [Line Items]
Warrants measurement input		0.71		0.71
Option Pricing Model | Exercise Price
Class Of Stock [Line Items]
Warrants measurement input							0.9
Option Pricing Model | Annualized Volatility
Class Of Stock [Line Items]
Warrants measurement input	87.73	61.4		61.4
Option Pricing Model | Dividend Yield
Class Of Stock [Line Items]
Warrants measurement input	0	0		0
Option Pricing Model | Measurement Input, Discount Rate
Class Of Stock [Line Items]
Warrants measurement input	0.16	2.51		2.51
Option Pricing Model | Exchange Rate
Class Of Stock [Line Items]
Warrants measurement input		1.29		1.29			1.31
Private Placement [Member]
Class Of Stock [Line Items]
Warrants purchase price per share							$ 0.9
Net proceeds from issuance of stock with warrants | $	$ 11,557
Payments of share issuance costs | $	$ 690
Expected Life		4 months 24 days		4 months 24 days
Private Placement [Member] | Share Capital with Unit Price of C$0.70
Class Of Stock [Line Items]
Units issued | shares	24,644,500
Units issued, price per unit							$ 0.7
Class C Multiple Voting Shares
Class Of Stock [Line Items]
Description of rights attached to each class of capital				800
Percentage of shares of one class held as a percentage of shares of another class		50%		50%
Units issued | shares				0		0

Share Capital and Equity - Summ

Share Capital and Equity - Summary of Voting Shares Activity (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Beginning Balance, Shares	594,181,604	538,851,252
Share capital issuances	43,731,290	55,330,352
Ending Balance, Shares	637,912,894	594,181,604
Class A Subordinate Voting Shares [Member]
Class of Stock [Line Items]
Beginning Balance, Shares	592,905,396	537,575,044
Share capital issuances	43,731,290	55,330,352
Ending Balance, Shares	636,636,686	592,905,396
Class C Multiple Voting Shares [Member]
Class of Stock [Line Items]
Beginning Balance, Shares	1,276,208	1,276,208
Share capital issuances	0	0
Ending Balance, Shares	1,276,208	1,276,208

Share Capital and Equity - Su_2

Share Capital and Equity - Summary of Share Capital and Equity (Details) - shares	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Class Of Stock [Line Items]
Number of shares outstanding	637,912,894	594,181,604	538,851,252
Class A Shares
Class Of Stock [Line Items]
Number of shares outstanding	636,636,686
Class C Shares
Class Of Stock [Line Items]
Number of shares outstanding	1,276,208
Class A Subordinate Voting Shares
Class Of Stock [Line Items]
Number of shares outstanding	636,636,686	592,905,396	537,575,044
Class C Multiple Voting Shares
Class Of Stock [Line Items]
Number of shares outstanding	1,276,208	1,276,208	1,276,208

Warrants - Summary of Warrants

Warrants - Summary of Warrants Outstanding to Purchase Shares (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Warrants and Rights Note Disclosure [Abstract]
Number of warrants, Beginning balance | shares	26,192,237
Number of warrants, Issued | shares	2,999,975
Number of warrants, Exercised | shares	(88,659)
Number of warrants, Ending balance | shares	29,103,553
Weighted average exercise price, Beginning balance | $ / shares	$ 0.75
Weighted average exercise price, Issued | $ / shares	1
Weighted average exercise price, Exercised | $ / shares	0.56
Weighted average exercise price, Ending balance | $ / shares	$ 0.75

Warrants - Summary of Warrant_2

Warrants - Summary of Warrants Outstanding And Exercisable (Details)	Jun. 30, 2022 $ / shares shares		Jun. 30, 2022 $ / shares shares		Dec. 31, 2021 shares
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	29,103,553		29,103,553		26,192,237
Exercise Price CAD 0.90
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	10,403,150		10,403,150
Exercise Price | $ / shares			$ 0.9	[1]
Expiry Date	Nov. 23, 2022		Nov. 23, 2022
Exercise Price CAD 0.70
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	209,426		209,426
Exercise Price | $ / shares			$ 0.7	[1]
Expiry Date	Nov. 23, 2022		Nov. 23, 2022
Exercise Price $0.82
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	12,135,922		12,135,922
Exercise Price | $ / shares	$ 0.82	[1]
Expiry Date	Dec. 17, 2022		Dec. 17, 2022
Exercise Price $0.67
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	2,230,080		2,230,080
Exercise Price | $ / shares	$ 0.67	[1]
Expiry Date	Jan. 29, 2023		Jan. 29, 2023
Exercise Price $1.00
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	2,999,975		2,999,975
Exercise Price | $ / shares	$ 1
Expiry Date	Apr. 13, 2024		Apr. 13, 2024
Exercise Price CAD 0.80
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	625,000		625,000
Exercise Price | $ / shares			$ 0.8	[1]
Expiry Date	Oct. 06, 2024		Oct. 06, 2024
Exercise Price CAD 0.80
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	500,000		500,000
Exercise Price | $ / shares			$ 0.8	[1]
Expiry Date	Oct. 06, 2025		Oct. 06, 2025
[1]Represents warrants that are exercisable as of June 30, 2022.

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - Equity Incentive Plan - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized share-based compensation expense	$ 390	$ 2,979	$ 1,428	$ 5,375
Class A Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of stock options available for grant, percentage of number of outstanding shares			10%
Minimum exercise price of stock options issued, percentage of fair market value of shares on grant date			100%
Maximum term of stock options granted			10 years

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Options Outstanding and Exercisable on an As-Converted Basis (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2022 $ / shares shares	Dec. 31, 2021 shares	Dec. 31, 2020 shares	Jun. 30, 2022 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options Outstanding	60,057,752	54,282,752	50,427,065	60,057,752
Exercisable Options	49,958,670			49,958,670
Life Remaining (years)	2 years 8 months 19 days	2 years 11 months 19 days	3 years 8 months 19 days
Stock Options Granted on July 31, 2019, One | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.1
Options Outstanding	6,245,840			6,245,840
Exercisable Options	6,245,840			6,245,840
Life Remaining (years)	2 years 2 months 19 days
Stock Options Granted on July 31, 2019, Two | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1
Options Outstanding	7,783,332			7,783,332
Exercisable Options	7,783,332			7,783,332
Life Remaining (years)	5 months 12 days
Stock Options Granted on July 31, 2019, Three | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1
Options Outstanding	1,166,667			1,166,667
Exercisable Options	1,166,667			1,166,667
Life Remaining (years)	1 year 3 months 7 days
Stock Options Granted on July 31, 2019, Four | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.5
Options Outstanding	508,333			508,333
Exercisable Options	508,333			508,333
Life Remaining (years)	1 year 11 months 12 days
Stock Options Granted on July 31, 2019, Five | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.5
Options Outstanding	800,000			800,000
Exercisable Options	800,000			800,000
Life Remaining (years)	1 year 11 months 15 days
Stock Options Granted on August 22, 2019, One | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.8
Options Outstanding	5,237,720			5,237,720
Exercisable Options	4,459,942			4,459,942
Life Remaining (years)	2 years 1 month 24 days
Stock Options Granted on August 22, 2019, Two | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1
Options Outstanding	6,150,000			6,150,000
Exercisable Options	5,522,222			5,522,222
Life Remaining (years)	2 years 1 month 24 days
Stock Options Granted on November 1, 2019 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.8
Options Outstanding	1,200,000			1,200,000
Exercisable Options	1,000,000			1,000,000
Life Remaining (years)	2 years 4 months 2 days
Stock Options Granted on February 3, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.8
Options Outstanding	348,333			348,333
Exercisable Options	148,333			148,333
Life Remaining (years)	2 years 7 months 6 days
Stock Options Granted on June 8, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.8
Options Outstanding	25,000			25,000
Exercisable Options	12,500			12,500
Life Remaining (years)	2 years 11 months 8 days
Stock Options Granted on July 31, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.8
Options Outstanding	1,200,000			1,200,000
Exercisable Options	1,150,000			1,150,000
Life Remaining (years)	3 years 1 month 2 days
Stock Options Granted on September 15, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.86
Options Outstanding	7,315,860			7,315,860
Exercisable Options	7,315,860			7,315,860
Life Remaining (years)	3 years 2 months 15 days
Stock Options Granted on October 2, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.77
Options Outstanding	3,000,000			3,000,000
Exercisable Options	3,000,000			3,000,000
Life Remaining (years)	3 years 3 months 3 days
Stock Options Granted on November 24, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 0.94
Options Outstanding	1,675,000			1,675,000
Exercisable Options	1,675,000			1,675,000
Life Remaining (years)	3 years 4 months 28 days
Stock Options Granted on December 2, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.11
Options Outstanding	2,900,000			2,900,000
Exercisable Options	2,900,000			2,900,000
Life Remaining (years)	3 years 5 months 4 days
Stock Options Granted on December 21, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.06
Options Outstanding	1,200,000			1,200,000
Exercisable Options	600,000			600,000
Life Remaining (years)	3 years 5 months 23 days
Stock Options Granted on March 18, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.63
Options Outstanding	6,375,000			6,375,000
Exercisable Options	4,158,333			4,158,333
Life Remaining (years)	3 years 8 months 19 days
Stock Options Granted on April 2, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.36
Options Outstanding	166,667			166,667
Exercisable Options	100,000			100,000
Life Remaining (years)	3 years 9 months 3 days
Stock Options Granted on April 21, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.58
Options Outstanding	175,000			175,000
Exercisable Options	116,667			116,667
Life Remaining (years)	3 years 9 months 21 days
Stock Options Granted on June 23, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.56
Options Outstanding	250,000			250,000
Exercisable Options	216,667			216,667
Life Remaining (years)	3 years 11 months 23 days
Stock Option Granted on November 11, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares	$ 1.33
Options Outstanding	25,000			25,000
Exercisable Options	6,250			6,250
Life Remaining (years)	4 years 4 months 13 days
Stock Option Granted on January 25, 2022 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares				$ 0.89
Options Outstanding	975,000			975,000
Exercisable Options	209,896			209,896
Life Remaining (years)	4 years 6 months 29 days
Stock Options Granted On February 1, 2022 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares				$ 0.84
Options Outstanding	100,000			100,000
Exercisable Options	20,556			20,556
Life Remaining (years)	4 years 7 months 2 days
Stock Options Granted On February 17, 2022 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares				$ 0.85
Options Outstanding	100,000			100,000
Exercisable Options	14,167			14,167
Life Remaining (years)	4 years 7 months 20 days
Stock Options Granted On March 1, 2022 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares				$ 1.09
Options Outstanding	200,000			200,000
Exercisable Options	33,333			33,333
Life Remaining (years)	4 years 8 months 1 day
Stock Options Granted On April 27, 2022 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares				$ 0.9
Options Outstanding	1,200,000			1,200,000
Exercisable Options	71,111			71,111
Life Remaining (years)	4 years 9 months 29 days
Stock Options Granted On June 17, 2022 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price | $ / shares				$ 0.77
Options Outstanding	3,735,000			3,735,000
Exercisable Options	723,661			723,661
Life Remaining (years)	4 years 11 months 19 days

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of Stock Option Activity (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2022 $ / shares shares	Jun. 30, 2022 $ / shares shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2020 $ / shares shares
Share-based Payment Arrangement [Abstract]
Number of Options, Beginning Balance | shares	54,282,752	54,282,752	50,427,065	50,427,065
Number of Options, Granted | shares	6,435,000	6,435,000	7,900,000	7,900,000
Number of Options, Exercised | shares	(51,975)	(51,975)	(2,737,326)	(2,737,326)
Number of Options, Forfeited/ Expired | shares	(608,025)	(608,025)	(1,306,987)	(1,306,987)
Number of Options, Ending Balance | shares	60,057,752	60,057,752	54,282,752	54,282,752	50,427,065
Weighted Average Price, Beginning Balance | $ / shares	$ 0.94		$ 0.84
Weighted Average Price, Granted | $ / shares	0.83		1.62
Weighted Average Price, Exercised | $ / shares		$ 0.8		$ 1.04
Weighted Average Price, Forfeited/ Expired | $ / shares	1.62		0.43
Weighted Average Price, Ending Balance | $ / shares	$ 0.92		$ 0.94		$ 0.84
Weighted Average Years	2 years 8 months 19 days	2 years 8 months 19 days	2 years 11 months 19 days	2 years 11 months 19 days	3 years 8 months 19 days
Weighted Average Years, Granted	5 years	5 years	5 years	5 years

Share-Based Compensation - Su_3

Share-Based Compensation - Summary of Stock Options Values using Black-Scholes Model with Key Assumptions (Details) - Equity Based Compensation Options - 4Front Holdings LLC	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-Free Interest Rate	2.42%
Risk-Free Interest Rate, minimum			0.87%
Risk-Free Interest Rate, maximum			0.92%
Expected Life (years)	5 years		5 years
Expected Annualized Volatility	71.30%
Expected Annualized Volatility, minimum			86.20%
Expected Annualized Volatility, maximum			93.53%
Forfeiture rate	0%	0%
Expected Dividend Yield	0%		0%

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	May 10, 2019
Leadership consulting Agreement In Force And Effect For A Period
Long term debt, Gross		$ 85,435
Pure Ratios | Online CBD Market
Leadership consulting Agreement In Force And Effect For A Period
Revenue from services to related party	$ 313		$ 313
MP Illinois | Nominee Agreement
Leadership consulting Agreement In Force And Effect For A Period
Percentage of beneficial interest		100%
LI Lending, LLC
Leadership consulting Agreement In Force And Effect For A Period
Percentage of ownership interest held		14.28%
Long-term Line of Credit				$ 48,300	$ 45,000
Debt instrument, Unamortized discount		$ 336
Long term debt, Gross		49,457
Debt instrument interest accrued		3,381
Outstanding debt amount		$ 49,121
Interest Rate		10.25%
Line of Credit Facility, exit fee		$ 9,000
LI Lending, LLC | Maha Consulting LLC
Leadership consulting Agreement In Force And Effect For A Period
Long-term Line of Credit		$ 54,000

Contingencies - Summary of Fair

Contingencies - Summary of Fair Value of Contingent Consideration (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Loss Contingencies [Line Items]
Balance					$ 2,393
Changes in fair value	$ (2,393)	$ 0	$ (2,393)	$ 0
Long-term portion	0		0		2,393
Om of Medicine
Loss Contingencies [Line Items]
Balance	0		0		$ 2,393
Changes in fair value			(2,393)
Long-term portion	$ 0		$ 0

Contingencies - Additional Info

Contingencies - Additional Information (Details) - USD ($)			3 Months Ended		6 Months Ended		12 Months Ended
	May 17, 2022	Jan. 26, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Sep. 01, 2022	Apr. 30, 2022
Loss Contingencies [Line Items]
Revenues			$ 28,439,000	$ 27,121,000	$ 54,487,000	$ 50,091,000
Contingent consideration payment			$ 1,373,000		$ 1,373,000				$ 412,000
Outstanding balance of contingent consideration							$ 2,393,000
Loss contingency damages sought value		$ 19,000,000
Loss Contingency Benefit Value		$ 129,000,000
Accrues interest rate								20%	10%
Litigation Settlement, Expense	$ 600,000
Accrues Interest [Member]
Loss Contingencies [Line Items]
Accrues interest rate			10%		10%
Om of Medicine
Loss Contingencies [Line Items]
Outstanding balance of contingent consideration			$ 0		$ 0		2,393,000
Om of Medicine | Revenue Milestone One | Minimum
Loss Contingencies [Line Items]
Revenues							$ 3,400,000
Om of Medicine | Revenue Milestone Two | Minimum
Loss Contingencies [Line Items]
Revenues					3,500,000
Om of Medicine | Revenue Milestone Two | Maximum
Loss Contingencies [Line Items]
Business combination contingent consideration payable			$ 6,900,000		$ 6,900,000

Financial instruments and fin_3

Financial instruments and financial risk management - Schedule of Fair Value Measurements With in the Fair Value Hierarchy of The Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Liabilities:
Derivative liability	$ 428	$ 3,502
Total liabilities	428	3,502
Fair Value, Inputs, Level 1 [Member]
Liabilities:
Derivative liability	0	0
Total liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities:
Derivative liability	0	0
Total liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Liabilities:
Derivative liability	428	3,502
Total liabilities	$ 428	$ 3,502

Financial Instruments and Fin_4

Financial Instruments and Financial Risk Management - Summary of Changes in Fair Value of the Derivative Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Derivative Liability [Abstract]
Balance, beginning of period	$ 3,502	$ 5,807
(Gain) loss on fair value of derivative liability	(3,074)	2,843
Change in fair value of derivative liability upon exercise of warrants	0	(1,427)
Balance, end of period	$ 428	$ 7,223

Financial Instruments and Fin_5

Financial Instruments and Financial Risk Management - Additional information (Details) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2022 CAD ($)
Investments, All Other Investments [Abstract]
Fair value, assets, level 1 to level 2 transfers, amount	$ 0	$ 0
Fair value, assets, level 2 to level 1 transfers, amount	0	0
Fair value, liabilities, level 1 to level 2 transfers, amount	0	0
Fair value, liabilities, level 2 to level 1 transfers, amount	0	0
Fair value, equity, level 1 to level 2 transfers, amount	0	0
Fair value, equity, level to level 1 transfers, amount	0	0
Fair value, transfers into (out of) level 3	0	0
Federally insured limits exceeded amount		10,866,000
Cash held with bank accounts	9,000
Maximum credit exposure	$ 15,823,000	$ 12,722,000
Due from banks			$ 9

Financial instruments and fin_6

Financial instruments and financial risk management - Schedule of Gross Contractual Obligations (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Financial Instruments [Line Items]
Less than 1 year	$ 27,657
1 to 3 years	91,899
3 to 5 years
Total	119,556
Accounts Payable and Accrued Liabilities [Member]
Financial Instruments [Line Items]
Less than 1 year	19,422
1 to 3 years	1,200
3 to 5 years
Total	20,622
Convertible Notes Notes Payable And Accrued Interest [Member]
Financial Instruments [Line Items]
Less than 1 year	8,235
1 to 3 years	74,699
Total	82,934
Contingent Consideration Payable [Member]
Financial Instruments [Line Items]
1 to 3 years	0
3 to 5 years
Total	0
Construction finance liability [Member]
Financial Instruments [Line Items]
Less than 1 year	0
1 to 3 years	16,000
Total	$ 16,000

Segment Information - Summary o

Segment Information - Summary of Revenues By Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Total Net Revenues	$ 28,439	$ 27,121	$ 54,487	$ 50,091
Total Depreciation and Amortization	1,123	861	1,970	1,635
Total Net Loss	6,551	6,223	12,450	17,312
Total Assets	320,457		320,457		$ 255,539
THC Cannabis
Segment Reporting Information [Line Items]
Total Net Revenues	28,195	26,396	53,978	48,544
Total Depreciation and Amortization	1,123	833	1,970	1,589
Total Net Loss	3,846	1,003	4,102	3,841
Total Assets	318,795		318,795		238,933
CBD Wellness
Segment Reporting Information [Line Items]
Total Net Revenues	244	725	509	1,547
Total Depreciation and Amortization	0	0	0	16
Total Net Loss	(104)	817	(119)	820
Total Assets	781		781		805
Corporate
Segment Reporting Information [Line Items]
Total Net Revenues			0	0
Total Depreciation and Amortization		28	0	30
Total Net Loss	2,809	$ 4,403	8,467	$ 12,651
Total Assets	$ 881		$ 881		$ 15,801

Segment Information - Additiona

Segment Information - Additional Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($) Segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Segment Information [Line Items]
Number of reportable segments | Segment	2
Goodwill	$ 42,037	$ 23,155	$ 23,155
Intangible assets, net	54,239	26,246
THC Cannabis
Segment Information [Line Items]
Goodwill	42,037	23,155
Intangible assets, net	54,239	26,246
CBD Wellness
Segment Information [Line Items]
Goodwill	0	0
Intangible assets, net	$ 0	$ 0

Supplementary Cash Flow Infor_3

Supplementary Cash Flow Information - Summary of Changes in Non-Cash Working Capital (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Changes in operating assets and liabilities
Accounts receivable and other receivables	$ (2,766)	$ (815)
Inventory	(5,302)	(4,563)
Prepaid expenses	(318)	50
Deposits	222	(70)
Accounts payable and accrued liabilities	4,939	65
Taxes payable	5,683	5,163
Equity attributable to 4Front Ventures Corp.	$ 2,458	$ (170)

Supplementary Cash Flow Infor_4

Supplementary Cash Flow Information - Summary of non-cash investing and financing activities (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Summary of Noncash Investing and Financing Activities [Line Items]
Exchange of convertible debt to equity	$ 3,122	$ 17,719
Change in right-of-use assets and lease liabilities	8	153
Issuance of equity to pay contingent consideration	0	883
Issuance of debt to pay contingent consideration	0	485
Equity portion of warrants recorded through derivative liability	0	1,427
Issuance of equity for NECC pursuant to acquisition	18,200	0
Property, plant, and equipment acquired through NECC acquisition	15,238	0
Issuance of notes payable in through NECC acquisition	2,000	0
Inventory acquired through NECC acquisition	213	0
Issuance of debt to acquire property and equipment	14	445
Inventory acquired through issuance of note payable	163	0
Cancellation of ROU asset and lease liability	2,020	0
Note payable issued to satisfy accrued expenses	961	0
Island Global Holdings, Inc. [Member]
Summary of Noncash Investing and Financing Activities [Line Items]
Issuance of equity for NECC pursuant to acquisition	6,245	0
Property, plant, and equipment acquired through NECC acquisition	2,214	0
ROU asset and lease liability acquired through Island acquisition	10,227	0
Issuance of notes payable in through NECC acquisition	10,000	0
Inventory acquired through NECC acquisition	3,072	0
Issuance of warrants for Island pursuant to acquisition	732	0
Note payable acquired through Island acquisition	$ 245	$ 0

Supplementary Cash Flow Infor_5

Supplementary Cash Flow Information - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 3,174	$ 1,662
Cash paid for income taxes	$ 2,100	$ 224

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Expense and Effective Tax Rates (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Net loss before income taxes	$ (3,504)	$ (2,867)	$ (5,960)	$ (11,298)
Income tax expense	$ (3,042)	$ (3,351)	$ (6,480)	$ (6,004)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	6 Months Ended
	Jun. 30, 2022
Federal Statute of Limitation
Income Taxes [Line Items]
Open tax year	2018
State Income Tax Returns
Income Taxes [Line Items]
Open tax year	2017